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Abstract
Anorectal emergencies comprise a wide variety of diseases that share common symptoms, i.e., anorectal pain or
bleeding and might require immediate management. While most of the underlying conditions do not need
inpatient management, some of them could be life-threatening and need prompt recognition and treatment. It is
well known that an incorrect diagnosis is frequent for anorectal diseases and that a delayed diagnosis is related to
an impaired outcome. This paper aims to improve the knowledge and the awareness on this specific topic and to
provide a useful tool for every physician dealing with anorectal emergencies.
The present guidelines have been developed according to the GRADE methodology. To create these guidelines, a
panel of experts was designed and charged by the boards of the World Society of Emergency Surgery (WSES) and
American Association for the Surgery of Trauma (AAST) to perform a systematic review of the available literature and to
provide evidence-based statements with immediate practical application. All the statements were presented and
discussed during the WSES-AAST-WJES Consensus Conference on Anorectal Emergencies, and for each statement, a
consensus among the WSES-AAST panel of experts was reached. We structured our work into seven main topics
to cover the entire management of patients with anorectal emergencies and to provide an up-to-date, easy-to-use tool
that can help physicians and surgeons during the decision-making process.
Keywords: Diagnosis, Non-operative management, Surgery, Antibiotics, Hemorrhoids, Fournier’s gangrene, Anorectal
bleeding, Anorectal sepsis, Anorectal foreign bodies , Anorectal Varices, Technique, Timing, Angiography, Embolization,
Guidelines
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Introduction
The definition of anorectal emergencies comprises a
wide variety of diseases that share presenting symptoms,
i.e., anorectal pain or bleeding, which may require im-
mediate management. While most of the underlying
conditions do not need inpatient management, some can
be life-threatening, requiring prompt recognition and
treatment. Making the correct initial diagnosis is prob-
ably the main issue in these cases, because the acute
pain could preclude a complete and accurate clinical
examination and the embarrassment related to the af-
fected anatomical region delays the presentation of the
patient in many cases. It is demonstrated that an incor-
rect recognition is frequent for anorectal diseases and
that a delayed diagnosis is related to an adverse outcome
[1]. Furthermore, anorectal disease remains a relevant
healthcare problem that can consume a considerable
amount of financial resource, both as direct costs related
to medical treatments and as indirect expenses, such as
loss of work days and impaired quality of life. In the
light of the above , it becomes clear how important it is
to spread knowledge in this field, improving diagnosis,
treatment, and outcomes of such a common condition.
Every physician working in an acute care setting will face
this set of pathologies. This paper aims to improve the
knowledge and the awareness on this specific topic and
to provide a useful tool for every physician dealing with
anorectal emergencies.
Notes on the use of the guidelines: aims, targets, and
limitations
These guidelines aim to present state of the art on diag-
nosis and therapeutic options for optimal management
of anorectal emergencies. The intent is to improve the
knowledge and the awareness of physicians around the
world on this specific topic, providing an up-to-date tool
that can help during the decision-making process. For
this reason, the guidelines are evidence-based and the
grade of recommendation is provided to summarize the
evidence available in the literature. The population con-
sidered in these guidelines consists of adult patients with
suspected anorectal emergencies. The practice guidelines
promulgated in this work do not represent a standard of
practice. They are suggested plans of care, based on the
best available evidence and consensus of experts, but
they do not exclude other approaches within the stand-
ard of practice. For example, they should not be used to
compel adherence to a given method of medical man-
agement, which should be determined after taking into
account the working conditions of each single medical
institution (staff levels, experience, equipment, etc.) and
the characteristics of the individual patient. However,
the responsibility for the results of treatment rests with
those who are directly engaged therein and not with the
consensus group.
Methods
To create these guidelines, a panel of experts was designed
and charged by the boards of the World Society of Emer-
gency Surgery (WSES) and of the American Association
for the Surgery of Trauma (AAST), to develop questions
on seven main topics that thoroughly cover the field of
this pathology (retained anorectal bodies, perineal necro-
tizing fasciitis, complicated hemorrhoids, acute anal
fissure, anorectal abscess, bleeding anorectal varices, com-
plicated anorectal prolapse). Leading specialists in the field
then were asked to perform a thorough search on each of
these topics in different databanks (MEDLINE, SCOPUS,
EMBASE) for relevant papers between 1985 and Novem-
ber 2019 and a systematic review of the available litera-
ture. They were asked to focus their search to provide
evidence-based answers to every question with immediate
practical application and to summarize them in state-
ments. Furthermore, the references were kept up to date
and the last literature search was performed in January
2021. All the statements were presented and discussed
during the WSES - AAST - WJES Consensus Conference
on Anorectal Emergencies held in Parma, Italy, on De-
cember 12, 2019, and for each statement, a consensus
among the WSES - AAST panelists was reached. An inter-
national expert panel discussed the different issues in sub-
sequent rounds. At each round, the manuscript was
revised and improved. The final version about which
agreement was reached resulted in the present manu-
script. All the members contributed to the development of
the manuscript.
The questions were created according to the PICO cri-
teria, and the following guidelines adopt the GRADE
methodology [2, 3].
Topics and questions
For clarity, we report the seven topics together with the
relative questions. The statements are summarized in
Table 1.
1) Anorectal abscess
A. In patients with a suspected anorectal abscess, what
is the role of clinical examination and biochemical
investigations?
B. In patients with a suspected anorectal abscess, what
are the appropriate imaging investigations?
C. In patients with an anorectal abscess, what are the
indications for surgical treatment and what is the
appropriate timing for surgery?
D. In patients with an anorectal abscess, what is the
role of wound packing after surgical drainage?
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Table 1 Statements
Anorectal abscess
1.A - In patients with a suspected anorectal abscess, what is the role of clinical examination and biochemical investigations?
- In patients with suspected anorectal abscess, we suggest to collect a focused medical history and to perform a complete physical examination,
including a digital rectal examination (weak recommendation based on low-quality evidence, 2C).
- In patients with suspected anorectal abscess, we suggest to check serum glucose, hemoglobin a1c, and urine ketones in order to identify an
undetected diabetes mellitus (strong recommendation based on low-quality evidence, 1C).
- In patients with suspected anorectal abscess and signs of systemic infection or sepsis, we suggest to request complete blood count, serum
creatinine, and inflammatory markers (e.g., C-reactive protein, procalcitonin, and lactates), to assess the status of the patient (weak recommendation
based on low-quality evidence, 2C).
1.B - In patients with a suspected anorectal abscess, what are the appropriate imaging investigations?
- In patients with suspected anorectal abscess, we suggest the use of imaging investigations in case of atypical presentation and in case of
suspicion of occult supralevator abscesses, complex anal fistula, or perianal Crohn’s disease. Suggested techniques are MRI, CT scan, or
endosonography according to the specific clinical scenario and the available skills and resources (weak recommendation based on low-quality evi-
dence, 2C).
1.C - In patients with an anorectal abscess, what are the indications for surgical treatment and what is the appropriate timing for surgery?
- In patients with anorectal abscess, we recommend a surgical approach with incision and drainage (strong recommendation based on low-quality
evidence, 1C).
- In patients with anorectal abscess, we suggest to base the timing of surgery on the presence and severity of sepsis (weak recommendation based
on low-quality evidence, 2C).
- In fit, immunocompetent patients with a small perianal abscess and without systemic signs of sepsis, we suggest considering an outpatient
management (weak recommendation based on low-quality evidence, 2C).
1.D - In patients with an anorectal abscess, what is the role of wound packing after surgical drainage?
- No recommendation can be made regarding the use of packing after drainage of an anorectal abscess, based on the available literature.
1.E - In patients with an anorectal abscess and concomitant fistula, what are the indications for fistula treatment in the acute setting?
- In patients with anorectal abscess and an obvious fistula, we suggest to perform a fistulotomy at the time of abscess drainage only in cases of
low fistula not involving sphincter muscle (i.e., subcutaneous fistula) (weak recommendation based on low-quality evidence, 2C).
- In patients with anorectal abscess and an obvious fistula involving any sphincter muscle, we suggest to place a loose draining seton (weak
recommendation based on low-quality evidence, 2C).
- In patients with anorectal abscess and no obvious fistula, we suggest against probing to search for a possible fistula, to avoid iatrogenic
complications (weak recommendation based on low-quality evidence, 2C).
1.F - In patients with an anorectal abscess, is there a role for antibiotic therapy and what is the appropriate antibiotic regimen?
- In patients with drained anorectal abscess, we suggest antibiotic administration in the presence of sepsis and/or surrounding soft tissue infection
or in case of disturbances of the immune response (weak recommendation based on low-quality evidence, 2C).
- In patients with anorectal abscess, we suggest sampling of drained pus in high-risk patients and/or in the presence of risk factors for multidrug-
resistant organism infection (weak recommendation based on very low-quality evidence, 2D).
Perineal necrotizing fasciitis (Fournier’s gangrene)
2.A - In patients with suspected Fournier’s gangrene, what is the role of clinical examination and biochemical investigations?
- In patients with suspected Fournier’s gangrene, we suggest to collect a focused medical history and a complete physical examination, including
a digital rectal examination (weak recommendation based on low-quality evidence, 2C).
- In patients with suspected Fournier’s gangrene and signs of systemic infection or sepsis, we suggest to request complete blood count and the
dosage of serum creatinine and electrolytes, inflammatory markers (e.g., C-reactive protein, procalcitonin), and blood gas analysis, to assess the sta-
tus of the patient (weak recommendation based on low-quality evidence, 2C). We also recommend to check serum glucose, hemoglobin a1c and
urine ketones in order to investigate an undetected diabetes mellitus (strong recommendation based on low-quality evidence, 1C).
- In patients with suspected Fournier’s gangrene, we suggest to use Laboratory Risk Indicator for Necrotising Fasciitis (LRINEC) score for an early
diagnosis and Fournier’s Gangrene Severity Index (FGSI) for prognosis and risk stratification (weak recommendation based on moderate quality
evidence, 2B).
2.B - In patients with suspected Fournier’s gangrene, which are the appropriate imaging investigations?
- In stable patients with suspected Fournier’s gangrene, we suggest to consider performing a CT scan (weak recommendation based on low-quality
evidence, 2C).
- In patients with Fournier’s gangrene, we recommend that imaging should not delay surgical intervention (strong recommendation based on
moderate quality evidence, 1B).
- In patients with Fournier’s gangrene and hemodynamic instability persisting after proper resuscitation, we suggest against CT imaging (weak
recommendation based on low-quality evidence, 2C).
2.C - In patients with Fournier’s gangrene, what are the indications for surgical treatment and what is the appropriate timing for surgery?
- In patients with Fournier’s gangrene, we recommend surgical intervention as soon as possible (strong recommendation based on low-quality evi-
dence, 1C).
- In patients with Fournier’s gangrene we suggest planning repeat surgical revisions (exploration and debridement) according to patient
conditions (weak recommendation based on low-quality evidence, 2C).
- In patients with Fournier’s gangrene, we suggest seriated surgical revisions until the patient is free of necrotic tissue (weak recommendation
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based on low-quality evidence, 2C).
2.D - In patients with Fournier’s gangrene, what is the appropriate surgical approach?
- In patients with Fournier’s gangrene, we suggest to remove all the necrotic tissue (weak recommendation based on low-quality evidence, 2C).
- In patients with Fournier’s gangrene, we suggest a multidisciplinary and tailored approach based upon the extent of perineal involvement, the
degree of fecal contamination, and the possible presence of sphincter or urethral damage (weak recommendation based on low-quality evidence,
2C).
- In patients with Fournier’s gangrene, we suggest to perform orchiectomy or other genital surgery only if strictly necessary and possibly based on
a urologic consultation (weak recommendation based on low-quality evidence, 2C).
- In patients with Fournier’s gangrene, we suggest planning the surgical management of early and delayed surgical sequelae with a
multidisciplinary and skilled team (weak recommendation based on low-quality evidence, 2C).
2.E - In patients with Fournier’s gangrene, which is the appropriate antibiotic regimen?
- In patients with Fournier’s gangrene, we recommend starting an empiric antimicrobial therapy as soon as the diagnosis is suspected (strong
recommendation based on moderate quality evidence, 1B).
- In patients with Fournier’s gangrene, we recommend that empiric antimicrobial therapy should include cover for gram-positive, gram-negative,
aerobic and anaerobic bacteria, and an anti-MRSA agent (strong recommendation based on moderate quality evidence, 1B).
- In patients with Fournier’s gangrene, we recommend to obtain microbiological samples at the index operation (strong recommendation based on
moderate quality evidence, 1B).
- In patients with Fournier’s gangrene, we recommend to base antimicrobial de-escalation on clinical improvement, cultured pathogens, and re-
sults of rapid diagnostic tests where available (strong recommendation based on moderate quality evidence, 1B).
Complicated hemorrhoid (thrombosed, strangulated, or bleeding)
3.A - In patients with suspected complicated hemorrhoids, what is the role of clinical examination and biochemical investigations?
- No recommendation can be made regarding the role of biochemical investigations in patients with suspected thrombosed or strangulated
hemorrhoids, based on the available literature.
- In patients with suspected bleeding hemorrhoids, we suggest to collect a focused medical history and to perform a complete physical
examination, including a digital rectal examination, to rule out other causes of lower gastrointestinal bleeding (weak recommendation based on
low-quality evidence, 2C).
- In patients with suspected bleeding hemorrhoids, we suggest to check vital signs, to determine hemoglobin and hematocrit, and to assess
coagulation to evaluate the severity of the bleeding (weak recommendation based on low-quality evidence, 2C). In case of severe bleeding, we
suggest blood typing and cross-matching (weak recommendation based on very low-quality evidence, 2D).
3.B - In patients with suspected complicated hemorrhoids, which are the appropriate imaging investigations?
- In patients with suspected complicated hemorrhoids, we suggest to perform imaging investigation (CT scan, MRI, or endoanal ultrasound) only if
there is suspicion of concomitant anorectal diseases (sepsis/abscess, inflammatory bowel disease, neoplasm) (weak recommendation based on low-
quality evidence, 2C).
3.C - In patients with complicated hemorrhoids, what is the role of endoscopy?
- In patients with complicated hemorrhoids, we suggest to perform anoscopy as part of the physical examination, whenever feasible and well
tolerated (low recommendation based on low-quality evidence, 2C).
- In patients with complicated hemorrhoids, we suggest to perform colonoscopy in case of concern for inflammatory bowel disease or cancer
arising from patient personal and family history, or from physical examination (low recommendation based on low-quality evidence, 2C).
3.D - In patients with complicated hemorrhoids, which is the appropriate pharmacological regimen?
- In patients with complicated hemorrhoids, we recommend non-operative management as first line therapy, with dietary and lifestyle changes
(i.e., increased fiber and water intake together with adequate bathroom habits) (strong recommendation based on moderate quality evidence, 1B).
- In patients with complicated hemorrhoids, we suggest to administer flavonoids to relieve symptoms (weak recommendation based on moderate
quality evidence, 2B).
- In patients with thrombosed or strangulated hemorrhoids, we suggest the use of topical muscle relaxant (weak recommendation based on low-
quality evidence, 2C).
- No recommendation can be made regarding the role of NSAIDs, topical steroids, other topical agents, or injection of local anesthetics for
complicated hemorrhoids, based on the available literature.
3.E - In patients with complicated hemorrhoids, what is the role of office-based procedures?
- No recommendation can be made regarding the role of office-based procedures (i.e., rubber band ligation, sclerotherapy, infrared coagulation) in
complicated hemorrhoids, based on the available literature.
3.F - In patients with complicated hemorrhoids, what are the indications for surgical treatment and what is the appropriate timing for surgery?
- In patients with thrombosed hemorrhoids, we suggest to base the decision between non-operative management and early surgical excision on
local expertise and patient’s preference (weak recommendation based on low-quality evidence, 2C).
- In patients with thrombosed hemorrhoids, we suggest against the use of incision and drainage of the thrombus (weak recommendation based on
low-quality evidence, 2C).
- No recommendation can be made regarding the role of surgery in patients with bleeding hemorrhoids, based on the available literature.
3.G - In patients with complicated hemorrhoids, what is the role of angiography?
- No recommendation can be made regarding the role of angiography in complicated hemorrhoids, based on the available literature.
Bleeding anorectal varices
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4.A - In patients with suspected bleeding anorectal varices, what is the role of clinical examination and biochemical investigations?
- In patients with suspected bleeding anorectal varices, we suggest to collect a focused medical history and to perform a complete physical
examination, including a digital rectal examination, to rule out other causes of lower gastrointestinal bleeding (weak recommendation based on
low-quality evidence, 2C).
- In patients with suspected anorectal varices, we suggest we suggest to check vital signs, to determine hemoglobin and hematocrit, and to
assess coagulation to evaluate the severity of the bleeding (weak recommendation based on low-quality evidence, 2C). In case of severe bleeding,
we suggest blood typing and cross-matching (weak recommendation based on very low-quality evidence, 2D).
4.B - In patients with suspected bleeding anorectal varices, which are the appropriate imaging investigations?
- In patients with bleeding anorectal varices, we suggest EUS +/- color Doppler evaluation as a second-line diagnostic tool, especially for deep rec-
tal varices or when in doubt (weak recommendation based on low-quality evidence, 2C).
- In patients with bleeding anorectal varices and failed detection of bleeding site at endoscopy and EUS, or whenever EUS is not available, we
suggest to perform contrast enhanced CT-scan (weak recommendation based on low-quality evidence, 2C).
- In pregnant patients with bleeding anorectal varices and failed US detection of bleeding site, we suggest to perform MRI angiography, if
available and if allowed by the clinical scenario (weak recommendation based on low-quality evidence, 2C).
4.C - In patients with suspected bleeding anorectal varices, what is the role of endoscopy?
- In patients with suspected bleeding anorectal varices, we suggest the use of ano-proctoscopy or flexible sigmoidoscopy as the first-line diagnos-
tic tool (weak recommendation based on low-quality evidence, 2C).
- In patients with suspected bleeding anorectal varices and high-risk features or evidence of ongoing bleeding, we suggest to perform an urgent
colonoscopy (plus upper endoscopy) within 24 hours of presentation (weak recommendation based on low-quality evidence, 2C).
- In patients with suspected bleeding anorectal varices and risk factors for colorectal cancer or suspicion of a concomitant more proximal source
of bleeding, we suggest to perform a full colonoscopy (weak recommendation based on low-quality evidence, 2C).
- In patients with bleeding anorectal varices, we suggest to use local procedures, such as endoscopic variceal ligation, endoscopic band ligation,
sclerotherapy, or EUS-guided glue injection, to arrest bleeding in first instance where feasible (weak recommendation based on low-quality evidence,
2C).
4.D - In patients with bleeding anorectal varices, what is the role of non operative management?
- In patients with bleeding anorectal varices, we suggest multidisciplinary management, early involving the hepatology specialist team and
focusing on optimal control of comorbid conditions (weak recommendation based on very low-quality evidence, 2D).
- In patients with anorectal varices and mild bleeding, we suggest intravenous fluid replacement, blood transfusion if necessary, correction of
coagulopathy, and optimal medication for portal hypertension (weak recommendation based on low-quality evidence, 2C).
- In patients with anorectal varices and severe bleeding, we recommend to maintain an Hb level of at least > 7 g/dl (4.5 mmol/l) during the
resuscitation phase and a mean arterial pressure > 65 mmhg, but avoiding fluid overload (strong recommendation based on moderate quality
evidence, 1B).
- In patients with bleeding anorectal varices, we suggest the endorectal placement of a compression tube as a bridging maneuver, to help
stabilization of the patient or to allow the transfer to a tertiary hospital (weak recommendation based on very low-quality evidence, 2D).
4.E - In patients with bleeding anorectal varices, which is the appropriate pharmacological regimen (including antibiotics)?
- In patients with anorectal varices, we suggest the use of non-selective beta-adrenergic blockers for prevention/prophylaxis of first and/or recur-
rent variceal bleeding (weak recommendation based on very low-quality evidence, 2D). In case of acute bleeding, we suggest to temporarily sus-
pended beta blockers (weak recommendation based on low-quality evidence, 2C).
- In patients with bleeding anorectal varices, we suggest to consider the use of vasoactive drugs, such as terlipressin or octreotide, to reduce
splanchnic blood flow and portal pressure (weak recommendation based on very low-quality evidence, 2D).
- In patients with bleeding anorectal varices, we recommend a short course of prophylactic antibiotic (strong recommendation based on moderate
quality evidence, 1B).
4.F - In patients with bleeding anorectal varices, what is the role for angiography?
- In patients with bleeding anorectal varices and failure of medical treatment and local procedures, we suggest a “step up” approach with
radiological and then surgical procedures (weak recommendation based on low-quality evidence, 2C).
- In patients with bleeding anorectal varices, we suggest to use embolization via interventional radiological techniques for the short-term control
of bleeding (weak recommendation based on low-quality evidence, 2C).
- In patients with bleeding anorectal varices and severe portal hypertension, we suggest to use percutaneous TIPS, if not contraindicated, to
decompress the portal venous system and to reduce the risk for rebleeding (weak recommendation based on low-quality evidence, 2C).
- No recommendation can be made regarding the superiority of one embolization technique over the others in case of bleeding anorectal varices
, based on the available literature.
4.G - In patients with bleeding anorectal varices, what are the indications for surgical treatment and what is the appropriate timing for surgery?
- In patients with bleeding anorectal varices and failure of medical treatment, local and radiological procedures, we suggest a “step up” approach
with surgical procedures (weak recommendation based on low-quality evidence, 2C).
- In patients with bleeding anorectal varices and failure of medical treatment, local and radiological procedures, we suggest against the use of “per
anal” suture ligation (weak recommendation based on very low-quality evidence, 2D).
- No recommendation can be made regarding the role of Doppler-guided hemorrhoidal artery ligation and stapled anopexy in patients with
bleeding anorectal varices and failure of medical treatment,local and radiological procedures, based on the available literature.
Complicated rectal prolapse (irreducible or strangulated)
5.A - In patients with a suspected complicated rectal prolapse, what is the role of clinical examination and biochemical investigations?
- In patients with suspected complicated rectal prolapse, we suggest to request complete blood count and the dosage of serum creatinine, and
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inflammatory markers (e.g., C-reactive protein, procalcitonin, and lactates) to assess the status of the patient (weak recommendation based on low-
quality evidence, 2C).
5.B - In patients with a suspected complicated rectal prolapse, which are the appropriate imaging investigations?
- In hemodynamically stable patients with irreducible or strangulated rectal prolapse, we suggest to perform an urgent contrast enhanced
abdomino-pelvic CT-scan, whenever available and without delaying appropriate treatment, to detect possible associated complications and to as-
sess the presence of a colorectal cancer (weak recommendation based on low-quality evidence, 2C).
- In hemodynamically unstable patients with irreducible or strangulated rectal prolapse, we suggest against delaying appropriate and timely
management to perform imaging investigations (weak recommendation based on low-quality evidence, 2C).
5.C - In patients with complicated rectal prolapse, what is the role of non-operative management?
- In patients with incarcerated rectal prolapse without signs of ischemia or perforation, we suggest to attempt conservative measures and gentle
manual reduction under mild sedation or anesthesia (weak recommendation based on moderate quality evidence, 2B).
- In hemodynamically unstable patients with complicated rectal prolapse, we suggest against delaying surgical management to attempt a
conservative management (weak recommendation based on low-quality evidence, 2C).
5.D - In patients with complicated rectal prolapse, what are the indications for surgical treatment and what is the appropriate timing for surgery?
- In patients with complicated rectal prolapse and signs of shock or gangrene/perforation of prolapsed bowel, we recommend immediate surgical
treatment (strong recommendation based on high-quality evidence, 1A).
- In patients with complicated rectal prolapse and bleeding, acute bowel obstruction or failure of non-operative management, we suggest urgent
surgical treatment (weak recommendation based on low-quality evidence, 2C).
5.E - In patients with complicated rectal prolapse, what is the most appropriate surgical approach?
- In patients with complicated rectal prolapse and no signs of peritonitis or hemodynamic instability, we suggest to base the decision between
abdominal and perineal procedures on the specific patient’s characteristics and on surgeon’s skills and expertise (weak recommendation based on
moderate quality evidence, 2B).
- In hemodynamically stable patients with complicated rectal prolapse, in case of abdominal approach, we suggest to base the decision between
open or laparoscopic surgery on patient’s characteristics and on surgeon’s skills and expertise (weak recommendation based on very low-quality evi-
dence, 2D).
- In patients with complicated rectal prolapse and signs of peritonitis, we suggest an abdominal approach (weak recommendation based on low-
quality evidence, 2C).
- In patients with complicated rectal prolapse and hemodynamic instability, we recommend an abdominal open approach (strong
recommendation based on low-quality evidence, 1C).
- In patients with complicated rectal prolapse undergoing resectional surgery, we suggest to base the decision between primary anastomosis, with
or without diverting ostomy, and terminal colostomy on the patient’s clinical condition and on the individual risk of anastomotic leakage (weak
recommendation based on low-quality evidence, 2C).
5.F - In patients with complicated rectal prolapse, which is the appropriate pharmacological regimen (antibiotics, pain-control, others)?
- In patients with strangulated rectal prolapse, we suggest to administer empiric antimicrobial therapy because of the risk of intestinal bacterial
translocation; the appropriate regimen should be based on the clinical condition of the patients, the individual risk for MDRO, and the local
resistance epidemiology (weak recommendation based on low-quality evidence, 2C).
Retained anorectal foreign bodies
6.A - In patients with a suspected retained anorectal foreign body, what is the role of clinical examination and biochemical investigations?
- In patients with suspected retained anorectal foreign body, we suggest to collect a focused medical history and to perform a complete physical
examination (weak recommendation based on low-quality evidence, 2C).
- In patients with suspected retained anorectal foreign body, we suggest to perform digital rectal examination after the acquisition of an abdomen
X-ray, whenever possible, to prevent accidental injury to the surgeon from sharp objects (weak recommendation based on low-quality evidence, 2C).
- In patients with suspected retained anorectal foreign body and no signs of bowel perforation, we suggest against routinely requesting of
laboratory tests (weak recommendation based on very low-quality evidence, 2D).
- In patients with suspected retained anorectal foreign body and no signs of bowel perforation, we suggest to request the routine preoperative
blood tests only in case manual extraction fails/is not feasible (weak recommendation based on very low-quality evidence, 2D).
- In patients with suspected retained anorectal foreign body and coexisting suspected bowel perforation, we suggest to request complete blood
count and the dosage of serum creatinine, and inflammatory markers (e.g., C-reactive protein, procalcitonin, and lactates) to assess the status of
the patient prior to surgery (weak recommendation based on low-quality evidence, 2C)
6.B - In patients with a suspected retained anorectal foreign body, which are the appropriate imaging investigations?
- In patients with suspected retained anorectal foreign body, we recommend lateral and anteroposterior plain X-ray film of the chest, abdomen,
and pelvis to identify the foreign body position and determine its shape, size, and location and the possible presence of pneumoperitoneum
(strong recommendation based on moderate quality evidence, 1B).
- In hemodynamically stable patients with suspected retained anorectal foreign body and a suspected perforation, we recommend a contrast
enhanced CT scan of the abdomen (strong recommendation based on moderate quality evidence, 1B).
- In patients with retained anorectal foreign body and hemodynamic instability, we suggest against delaying surgical treatment to perform
imaging investigations (weak recommendation based on low-quality evidence, 2C).
6.C - In patients with a retained anorectal foreign body, what is the most appropriate interventional approach (manual extraction vs endoscopy vs
surgery)?
- In patients with low-lying retained anorectal foreign body without sign of perforation, we suggest an attempt of bedside extraction as the first-
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line therapy (weak recommendation based on low-quality evidence, 2C).
- No recommendation can be made regarding the superiority of one trans-anal extraction technique over the others in case of retained anorectal
foreign body, based on the available literature.
- In patients with retained anorectal foreign body and failure of bedside extraction, we suggest pudendal nerve block, spinal anesthesia,
intravenous conscious sedation, or general anesthesia to improve chances of transanal retrieval (weak recommendation based on low-quality evi-
dence, 2C).
- In patients with retained high-lying anorectal foreign body (above rectosigmoid junction), we suggest an attempt of endoscopic extraction as
the first-line therapy (weak recommendation based on low-quality evidence, 2C).
- In patients with retained anorectal foreign body and suspect of drug concealment, we suggest against any maneuver that can disrupt the drug
package, including endoscopic retrieval (weak recommendation based on low-quality evidence, 2C).
- In patients with retained anorectal foreign body, we suggest to perform a proctoscopy or flexible sigmoidoscopy after foreign body removal, to
evaluate bowel wall status (weak recommendation based on low-quality evidence, 2C).
- In patients with retained anorectal foreign body and signs and hemodynamic instability or perforation, we recommend against transanal
extraction (strong recommendation based on low-quality evidence, 1C).
6.D - In patients with a retained anorectal foreign body, what are the indications for surgical treatment and what is the appropriate timing for
surgery?
- In patients with retained anorectal foreign body and no signs of perforation, we suggest a surgical approach in case of failure of transanal
extraction (weak recommendation based on low-quality evidence, 2C).
- In patients with retained anorectal foreign body and no signs of perforation, we suggest a “step-up” surgical approach, starting with downward
milking and proceeding to colotomy only when milking/transanal extraction fails (weak recommendation based on low-quality evidence, 2C).
- In patients with retained anorectal foreign body and no signs of perforation, we suggest a laparoscopic approach if skills and instrumentation are
available (weak recommendation based on low-quality evidence, 2C).
- In patients with retained anorectal foreign body and bowel perforation with limited peritoneal contamination, we suggest primary suture only in
case of small and recent perforation and if the colonic tissues appear healthy and well vascularized, and an approximation of perforation edges
could be performed without tension (weak recommendation based on low-quality evidence, 2C)
- In patients with retained anorectal foreign body and bowel perforation, clinically stable and without risk factors for anastomotic leakage, when
primary suture is not feasible, we suggest resection with primary anastomosis with or without a diverting stoma (weak recommendation based on
low-quality evidence, 2C)
- In critically ill patients with retained anorectal foreign body and bowel perforation, or in selected patients with extensive peritoneal
contamination and risk factors for anastomotic leakage, we suggest to perform a Hartmann’s procedure (weak recommendation based on low
quality evidence, 2C)
- In patients with retained anorectal foreign body and hemodynamic instability, we recommend an emergent laparotomy and a damage control
surgery approach (strong recommendation based on moderate quality evidence, 1B).
6.E - In patients with a retained anorectal foreign body, is there a role for antibiotic therapy?
- In patients with retained anorectal foreign body, we suggest against the routinely use of antimicrobial therapy (weak recommendation based on
low-quality evidence, 2C).
- In patients with retained anorectal foreign body and signs of hemodynamic instability or perforation, we recommend broad spectrum antibiotic
therapy according to the WSES guidelines on intra-abdominal infections (strong recommendation based on moderate quality evidence, 1B).
Acute anal fissure
7.A - In patients with suspected acute anal fissure, what is the role of clinical examination and biochemical investigations?
- No recommendation can be made regarding the role of biochemical investigations in patients with typical acute anal fissure, based on the
available literature
- In patients with atypical acute anal fissure, we suggest to collect a focused medical history, perform a complete physical examination and
laboratory tests based on the suspected associated illness, to rule out other causes (weak recommendation based on low-quality evidence, 2C).
7.B - In patients with suspected acute anal fissure, which are the appropriate imaging investigations?
- No recommendation can be made regarding the use of imaging investigations in patients with typical acute anal fissure, based on the available
literature.
- In patients with atypical acute anal fissure, we suggest to perform investigations (endoscopy, CT scan, MRI, or endoanal ultrasound) only in case
of suspected concomitant inflammatory bowel disease,anal or colorectal cancer or occult perianal sepsis (weak recommendation based on low-
quality evidence, 2C).
7.C - In patients with an acute anal fissure, what is the role of non-operative management?
- In patients with acute anal fissure, we recommend non-operative management as the first-line treatment (Strong recommendation based on mod-
erate quality evidence, 1B)
- In patients with acute anal fissure, we recommend dietary and lifestyle changes, with increased fiber and water intake (strong recommendation
based on moderate quality evidences, 1B).
- In patients with acute anal fissure, we recommend against the use of manual dilatation (strong recommendation based on moderate quality
evidences, 1B).
- No recommendation can be made regarding the use of controlled anal dilatation in patients with acute anal fissure, based on the available
literature.
7.D - In patients with an acute anal fissure, what is the appropriate approach for pain control?
- In patients with acute anal fissure, we suggest the integration of topical anesthetics and common pain killers in case of inadequate pain control
(weak recommendation based on low-quality evidences, 2C).
- No recommendation can be made regarding the use of botulinum injections in patients with acute anal fissure, based on the available literature.
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E. In patients with an anorectal abscess and
concomitant fistula, what are the indications for
fistula treatment in the acute setting?
F. In patients with an anorectal abscess, is there a role
for antibiotic therapy and what is the appropriate
antibiotic regimen?
2) Perineal necrotizing fasciitis (Fournier’s gangrene)
A. In patients with suspected Fournier’s gangrene,
what is the role of clinical examination and
biochemical investigations?
B. In patients with suspected Fournier’s gangrene,
which are the appropriate imaging investigations?
C. In patients with Fournier’s gangrene, what are the
indications for surgical treatment and what is the
appropriate timing for surgery?
D. In patients with Fournier’s gangrene, what is the
most appropriate surgical approach?
E. In patients with Fournier’s gangrene, which is the
appropriate antibiotic regimen?
3) Complicated hemorrhoids (thrombosed, strangulated, or
bleeding)
A. In patients with suspected complicated
hemorrhoids, what is the role of clinical
examination and biochemical investigations?
B. In patients with suspected complicated
hemorrhoids, which are the appropriate imaging
investigations?
C. In patients with complicated hemorrhoids, what is
the role of endoscopy?
D. In patients with complicated hemorrhoids, which is
the appropriate pharmacological regimen?
E. In patients with complicated hemorrhoids, what is
the role of office-based procedures?
F. In patients with complicated hemorrhoids, what are
the indications for surgical treatment and what is
the appropriate timing for surgery?
G. In patients with complicated hemorrhoids, what is
the role of angiography?
4) Bleeding anorectal varices
A. In patients with suspected bleeding anorectal
varices, what is the role of clinical examination and
biochemical investigations?
B. In patients with suspected bleeding anorectal
varices, which are the appropriate imaging
investigations?
C. In patients with suspected bleeding anorectal
varices, what is the role of endoscopy? D In patients
with bleeding anorectal varices, what is the role of
non-operative management?
D. E. In patients with bleeding anorectal varices, which
is the appropriate pharmacological regimen
(including antibiotics)?
E. F. In patients with bleeding anorectal varices, what
is the role for angiography?
F. G. In patients with bleeding anorectal varices, what
are the indications for surgical treatment and what
is the appropriate timing for surgery?
5) Complicated rectal prolapse (irreducible or strangulated)
A. In patients with suspected complicated rectal
prolapse, what is the role of clinical examination
and biochemical investigations?
B. In patients with suspected complicated rectal prolapse,
which are the appropriate imaging investigations?
C. In patients with complicated rectal prolapse, what is
the role of non-operative management?
D. In patients with complicated rectal prolapse, what
are the indications for surgical treatment and what
is the appropriate timing for surgery?
E. In patients with complicated rectal prolapse, what is
the most appropriate surgical approach?
F. In patients with complicated rectal prolapse, which
is the appropriate pharmacological regimen
(antibiotics, pain-control, others)?
6) Retained anorectal foreign bodies
A. In patients with a suspected retained anorectal
foreign body, what is the role of clinical
examination and biochemical investigations?
Table 1 Statements (Continued)
7.E - In patients with an acute anal fissure, is there a role for antibiotic therapy?
- In patients with acute anal fissure, we suggest the use of topical antibiotics in case of potential reduced therapeutic compliance or poor genital
hygiene (weak recommendation based on very low-quality evidences, 2D).
7.F - In patients with an acute anal fissure, what are the indications for surgical treatment and what is the appropriate timing for surgery? If indicated,
what is the most appropriate surgical approach?
- In patients with acute anal fissure, we suggest against surgical treatment (weak recommendation based on moderate quality evidences, 2B).
- In patients with anal fissure, we suggest surgical treatment in the chronic phase, if non responsive after 8 weeks non-operative management
(strong recommendation based on moderate quality evidences, 1B).
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B. In patients with a suspected retained anorectal
foreign body, which are the appropriate imaging
investigations?
C. In patients with a retained anorectal foreign body,
what is the most appropriate interventional
approach (manual extraction vs endoscopy vs
surgery)?
D. In patients with a retained anorectal foreign body,
what are the indications for surgical treatment and
what is the appropriate timing for surgery?
E. In patients with a retained anorectal foreign body, is
there a role for antibiotic therapy?
7) Acute anal fissure
A. In patients with a suspected acute anal fissure, what
is the role of clinical examination and biochemical
investigations?
B. In patients with a suspected acute anal fissure,
which are the appropriate imaging investigations?
C. In patients with an acute anal fissure, what is the
role of non-operative management?
D. In patients with an acute anal fissure, what is the
appropriate approach for pain control?
E. In patients with an acute anal fissure, is there a role
for antibiotic therapy?
F. In patients with an acute anal fissure, what are the
indications for surgical treatment and what is the
appropriate timing for surgery? If indicated, what is
the most appropriate surgical approach?
Guidelines
1) Anorectal abscess
1.A - In patients with a suspected anorectal
abscess, what is the role of clinical
examination and biochemical investigations?
In patients with suspected anorectal abscess, we sug-
gest to collect a focused medical history and to per-
form a complete physical examination, including a
digital rectal examination (weak recommendation
based on low-quality evidence, 2C).
In patients with suspected anorectal abscess, we sug-
gest to check serum glucose, hemoglobin a1c, and
urine ketones in order to identify an undetected dia-
betes mellitus (strong recommendation based on
low-quality evidence, 1C).
In patients with suspected anorectal abscess and
signs of systemic infection or sepsis, we suggest to re-
quest a complete blood count, serum creatinine, and
inflammatory markers (e.g., C-reactive protein, pro-
calcitonin, and lactates), to assess the status of the
patient (weak recommendation based on low-quality
evidence, 2C).
An anorectal abscess is characterized by an infection
in the soft tissue around the anus. However, depending
on the different anatomical locations of the infectious
process, the manifestations, and the treatment of anorec-
tal abscesses vary widely. It is important to remember
the anatomical classification of intersphincteric, perianal,
ischiorectal, or supralevator abscesses [4]. Anorectal ab-
scesses are associated with anal fistulas in approximately
a third of patients [5], and the classification of fistulae
depends on their anatomical location as well. The clin-
ical presentation is typically characterized by perianal
pain, swelling, and fever, but deeper abscesses may also
present with pain referred to the perineum, low back,
and buttocks or with symptoms that mimic an intra-
abdominal condition; discharge of pus could also be
present and occasionally patients with anorectal ab-
scesses will present with urinary retention [6]. It is a
common disease and constitutes a common presentation
to emergency general surgeons; the most common age
for presentation is 20–40 years, with men more com-
monly affected than women [7, 8]. The majority are idio-
pathic in nature, with the cryptoglandular hypothesis
being most commonly accepted, but a proportion may
present as part of another disease process, most com-
monly Crohn’s disease. The differential diagnosis of ano-
rectal abscesses is wide and comprises other significant
diseases such as anal cancer and precancerous condi-
tions, Crohn’s disease, and tuberculosis. In fact, an ano-
rectal abscess will develop in approximately one third of
patients with Crohn’s disease [9]. Furthermore, it is im-
portant to make an early distinction from Fournier’s
gangrene/necrotizing fasciitis. The most common ana-
tomical locations are perianal and ischio-rectal, with
intersphincteric and supralevator being less common.
The management of patients with known Crohn’s dis-
ease goes beyond the aims of these guidelines, but it is
mandatory to exclude the presence of undiagnosed
underlying Crohn’s disease in every patient presenting
with an anorectal abscess, especially if recurrent [10].
For this reason, a focused and detailed medical history is
of utmost importance and complete physical examin-
ation should include a careful inspection of the peri-
neum checking for surgical scars, anorectal deformities,
other signs of perianal Crohn’s disease, the presence of
secondary cellulitis, or the presence of external opening
of an anal fistula. A complete anorectal examination, in-
cluding digital rectal examination, is usually feasible, but
in some cases, sedation or anesthesia may be needed due
to the intense pain. The patient’s history and physical
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examination are usually enough to diagnose small and
superficial abscesses [11] , while deeper abscesses can be
challenging to diagnose; in these cases, rectal examin-
ation usually reveals a tender, indurated area above the
anorectal ring.
Laboratory and radiological studies are not usually
needed for the diagnosis of an anorectal abscess but can
be useful in specific situations. The decision to perform
laboratory tests to assess the severity of illness should be
guided by the clinical findings. Routine laboratory tests
can provide an insight on the general health status of
the patient and can help physicians understand the se-
verity of the situation, especially in case of potential can-
didates for emergency surgery or with signs of
hemodynamic instability.
It is important to remember that symptoms are fre-
quently absent or diminished in older and debilitated pa-
tients, in patients with diabetes or other forms of
immunosuppression, and in some cases of associated
necrotizing soft-tissue infection [11]: for this reason, the
treatment of these subsets of patients requires a great
degree of suspicion and an aggressive approach.
1.B - In patients with a suspected anorectal abscess,
what are the appropriate imaging investigations?
In patients with suspected anorectal abscess, we sug-
gest the use of imaging investigations in case of atyp-
ical presentation and in case of suspicion of occult
supralevator abscesses, complex anal fistula, or peri-
anal Crohn’s disease. Suggested techniques are MRI,
CT scan, or endosonography according to the specific
clinical scenario and the available skills and re-
sources (weak recommendation based on low-quality
evidence, 2C).
Radiological studies are not usually needed for the diag-
nosis of an anorectal abscess but can be useful in some
special situations. The use of imaging techniques could be
helpful in all those cases with an atypical presentation
(e.g., lower back pain, severe anal pain in the absence of a
fissure, urinary retention), when the physical examination
suggests a supralevator or intersphincteric abscess or
when there is suspicion of perianal Crohn’s disease. Fistu-
lography used to be the method of choice for the radio-
logical assessment of fistula-in-ano, but its accuracy rate
could be as low as 16% [12] and nowadays has been re-
placed by more accurate imaging techniques.
MRI has high detection rates for anorectal abscesses
[13], while there is debate around the sensitivity and
specificity of anal endosonography (EUS). Some studies
suggest that EUS is more accurate than MRI in detecting
abscesses and in the evaluation of complex fistulas,
especially when an underlying Crohn’s disease is sus-
pected [14], while others report an undisputed superior-
ity of MRI [15]. However, these imaging techniques have
some downsides: access to emergency MRI is often lim-
ited and it requires a long acquisition time, while EUS
requires special skills and its use in an awake patient in
the emergency setting is almost always precluded by in-
tense anal pain. In this scenario, the use of CT scan of-
fers multiple advantages, such as its short acquisition
time and widespread availability. The main factor limit-
ing CT’s accuracy is its poor spatial resolution in the
pelvis and the difficulty to differentiate between a fistula
tract and inflammation, because the tissue characteristics
are very similar [16]. An old, small prospective trial
found that CT scan was far less accurate than EUS in
detecting fistulae, while the two methods were equiva-
lent in the diagnosis of anorectal abscesses [17]. A retro-
spective study on 113 patients with anorectal abscesses
found a 77% overall sensitivity of CT in detecting peri-
rectal abscess, and this lack of sensitivity reduced further
in immunocompromised patients [18]. Furthermore,
some authors suggest that CT fistulography, with its ac-
curacy rate of 81.1%, could be a helpful tool in selecting
the most appropriate surgical treatment [19], but the
population included in this prospective study is too
small to make recommendations and does not relate to
emergency presentations. The use of point-of-care trans-
perineal ultrasound is emerging as a valid tool to diag-
nose perineal and perirectal abscesses in the emergency
department. The advantages of this technique are mul-
tiple, but the results are highly operator sensitive due to
the complex anatomy of the involved region and the
substantial variability in patient presentation and loca-
tion of rectal abscesses. In recent review, sonography
demonstrated high accuracy in the identification of peri-
anal abscesses [20], but the available evidence is too
scarce to make a recommendation.
In conclusion, CT, MRI, and EUS could have a role in
the diagnosis of perianal abscesses, with the principal
aims of excluding related conditions and correctly deter-
mining the regional anatomy and extent of the disease;
the choice of the appropriate imaging investigation
should take into account multiple factors, such as pa-
tient’s past medical history, clinical presentation, local
availability of resources, and skills. After the resolution
of the acute phase, routine imaging after incision and
drainage of the anorectal abscess is usually not required.
An imaging follow-up is otherwise suggested in cases of
recurrence, in the presence of suspected IBD and when
there is evidence of a fistula and/or non-healing wound.
1.C - In patients with an anorectal abscess, what
are the indications for surgical treatment and what
is the appropriate timing for surgery?
Tarasconi et al. World Journal of Emergency Surgery           (2021) 16:48 Page 10 of 45
In patients with anorectal abscess, we recommend a
surgical approach with incision and drainage (strong
recommendation based on low-quality evidence, 1C).
In patients with anorectal abscess, we suggest to base
the timing of surgery on the presence and severity of
sepsis (weak recommendation based on low-quality
evidence, 2C).
In fit, immunocompetent patients with a small peri-
anal abscess and without systemic signs of sepsis we
suggest considering an outpatient management (weak
recommendation based on low-quality evidence, 2C).
The primary treatment of anorectal abscesses remains
surgical drainage, with the timing being dictated by the se-
verity and nature of any sepsis. In general, the incision
should be kept as close as possible to the anal verge to
minimize the length of a potential fistula, while still pro-
viding adequate drainage and avoiding sphincteral damage
[21]. It is important to stress the high rate of recurrence
after drainage, which can be as high as 44% [22, 23]. The
risk factors associated with recurrence are inadequate
drainage, loculations, horseshoe-type abscess, and time
from disease onset to incision [23, 24]. The high recur-
rence rate and the associated risk factors emphasize the
need for a complete and accurate drainage of the abscess.
A recent randomized prospective study on needle aspir-
ation treatment vs. incision and drainage of acute simple
perianal abscess emphasized the importance of a complete
drainage of the perianal abscess, with recurrence rates of
41% following needle aspiration compared to 15% after in-
cision and drainage [25].
Young, fit patients without any signs of sepsis may
have their surgery undertaken in an ambulatory setting,
and small simple perianal abscesses may be treated
under local anesthesia. While perianal and ischioanal ab-
scesses should be treated via incision and drainage of
the overlying skin, intersphincteric abscess should be
drained into the rectal lumen and a limited internal
sphincterotomy may be required [26]. Supralevator ab-
scess may require drainage via the rectal lumen (if ex-
tension of an intersphincteric abscess) or externally via
the skin (if extension of ischioanal abscess) [27, 28].
The timing for surgery is dictated by the patient’s clin-
ical condition and comorbidities: the presence of sepsis,
severe sepsis or septic shock, immunosuppression, dia-
betes mellitus, and diffuse cellulitis should prompt an
emergent drainage. In the absence of these factors, the
surgical drainage should ideally be performed within 24 h.
1.D - in patients with an anorectal abscess, what is
the role of wound packing after surgical drainage?
No recommendation can be made regarding the use
of packing after drainage of an anorectal abscess,
based on the available literature.
Common practice is to place an internal dressing
(pack) into the cavity following incision and drainage of
an anorectal abscess, both for hemostasis and to prevent
the premature closure of the skin; the pack is then chan-
ged regularly until the cavity heals. Some authors sug-
gest placing a catheter or drain into the abscess cavity,
which drains into an external dressing, with a small stab
incision under local anesthetic and to leave it in place
until it stops draining.
Despite being commonly performed, the role of wound
packing after anorectal abscess drainage remains unproven.
Those supporting its use suggest a reduced time to healing
and a reduced incidence of recurrence, but patients may ex-
perience pain during the process, and there is additional
healthcare expense with its prolonged use. A recent
Cochrane review [29] included two studies for a total of 64
randomized participants, and both included studies were at
high risk for bias. For these reasons, the authors stated that
it “is unclear whether using internal dressings (packing) for
the healing of perianal abscess cavities influences time to
healing, wound pain, development of fistulae, abscess recur-
rence, or other outcomes” and, as such, its use should be
left to individual unit policy and patient discussion. A sub-
sequent multi-center observational study was performed,
enrolling 141 patients undergoing incision of primary ano-
rectal abscess and subsequent packing. The conclusions of
the authors were that packing is costly and painful and does
not add benefit to the healing process [30]. Hopefully, an
on-going randomized trial in the UK (PPAC2) may shed
light on this in due course.
1.E - in patients with an anorectal abscess with a
concomitant fistula, what are the indications for
fistula treatment in the acute setting?
In patients with anorectal abscess and an obvious
fistula, we suggest to perform a fistulotomy at the
time of abscess drainage only in cases of low fistula
not involving sphincter muscle (i.e., subcutaneous fis-
tula) (weak recommendation based on low-quality
evidence, 2C).
In patients with anorectal abscess and an obvious
fistula involving any sphincter muscle, we suggest to
place a loose draining seton (weak recommendation
based on low-quality evidence, 2C).
In patients with anorectal abscess and no obvious
fistula, we suggest against probing to search for a
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possible fistula, to avoid iatrogenic complications
(weak recommendation based on low-quality evi-
dence, 2C).
A third of perianal abscesses may manifest a fistula-in-
ano which increases the risk of abscess recurrence re-
quiring repeat surgical drainage [31]. The edema and
anatomical distortion that may be present with acute in-
fection imply that the treating surgeon should be very
cautious approaching an associated anal fistula. If an ob-
vious fistula is found at the time of anorectal abscess
drainage, this may only be laid open if deemed to be
subcutaneous by an experienced surgeon, as treatment
of an anal fistula at the time of abscess drainage is asso-
ciated with a lower rate of recurrent abscess/fistula and
need for further surgery. This has been confirmed by a
prospective study by Schouten et al. [32], which found
that primary fistulectomy with partial internal sphincter-
ectomy performed at the time of abscess drainage highly
reduced the recurrence rate, but was also associated with
increased anal function disturbances; the authors con-
cluded that fistulectomy should thus be reserved as a
second stage procedure, if necessary. A 2010 Cochrane
review [33] included six trials comparing incision and
drainage of perianal abscess alone versus incision and
drainage with fistula treatment, for a total of 479 pa-
tients. Their meta-analysis showed a significant reduc-
tion in recurrence, persistent abscess/fistula, or repeat
surgery in favor of fistula surgery at the time of abscess
incision and drainage, but this result is burdened by an
increased, albeit statistically insignificant, incidence of
continence disturbances at 1-year follow-up. According
to these results, no attempt should be made to probe or
use hydrogen peroxide to search for a possible fistula, in
order to avoid iatrogenic complications. If there is suspi-
cion of any sphincteric muscle involvement, then a loose
draining seton [32, 34, 35] should be placed and subse-
quent management options should be discussed with the
patient to avoid the risk of incontinence.
1.F - in patients with an anorectal abscess, is there
a role for antibiotic therapy and what is the
appropriate antibiotic regimen?
In patients with drained anorectal abscess, we
suggest antibiotics administration in the presence
of sepsis and/or surrounding soft tissue infection
or in case of disturbances of the immune response
(weak recommendation based on low-quality
evidence, 2C).
In patients with anorectal abscess, we suggest sam-
pling of drained pus in high-risk patients and/or in
the presence of risk factors for multidrug-resistant or-
ganism infection (weak recommendation based on
very low-quality evidence, 2D).
A recent meta-analysis tried to shed light on the role
of antibiotics after drainage of anorectal abscess. The
meta-analysis included six studies for a total of 817 pa-
tients, of which 358 (43.8%) underwent management
without antibiotics while 459 (56.2%) patients were
treated with antibiotics: the fistula rate in subjects re-
ceiving antibiotics was 16% versus 24% in those not re-
ceiving postoperative antibiotics, with a 36% lower odds
of fistula formation [36]. The authors concluded that an
empiric 5–10 day course of antibiotics following opera-
tive drainage may reduce the incidence of post-operative
fistula, but the evidence is low and they do not specify
duration and type of antibiotics. One of the included
studies retrospectively analyzed 172 patients with un-
complicated anorectal abscess and compared the out-
comes of incision and drainage alone with incision and
drainage plus 5 to 7 days of oral antibiotic therapy: they
interestingly found that among patients with anorectal
abscess complicated by surrounding cellulitis, indur-
ation, or systemic sepsis and treated with drainage alone,
there was a 2-fold increase in recurrent abscess [36].
Conversely, the role of antibiotics is pivotal in neutro-
penic or otherwise immunosuppressed patients [37–41].
Furthermore, 2007 guidelines from the American Heart
Association recommend administration of antibiotics be-
fore incision and drainage of the infected tissue in pa-
tients with prosthetic valves, previous bacterial
endocarditis, congenital heart disease, and heart trans-
plant recipients with valve pathology [42], while the role
of prophylaxis in patients with bicuspid aortic valves and
mitral valve prolapse remains debated [43].
Although routine cultures of drained pus are usu-
ally considered unnecessary [44], there are studies
that highlight how the prevalence of methicillin-
resistant Staphylococcus aureus (MRSA) in routine
anorectal abscesses can be as high as 35% [45, 46].
For this reason, we suggest to consider sampling of
drained pus in cases with risk factors for multidrug-
resistant organism (MDRO) infection, in case of re-
current infections or non-healing wounds and in
high-risk patients (e.g., HIV, immunocompromised
patients, etc.) [44–47].
We refer to the WSES guidelines for soft-tissue [48]
and intra-abdominal infections [49] for a discussion of
the appropriate antibiotics regimens.
2. Perineal necrotizing fasciitis (Fournier’s gangrene)
2.A - in patients with suspected Fournier’s
gangrene, what is the role of clinical
examination and biochemical investigations?
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In patients with suspected Fournier’s gangrene, we
suggest to collect a focused medical history and a
complete physical examination, including a digital
rectal examination (weak recommendation based on
low-quality evidence, 2C).
In patients with suspected Fournier’s gangrene and
signs of systemic infection or sepsis, we suggest to re-
quest complete blood count and the dosage of serum
creatinine and electrolytes, inflammatory markers
(e.g., C-reactive protein, procalcitonin) and blood gas
analysis, to assess the status of the patient (weak rec-
ommendation based on low-quality evidence, 2C).
We also recommend to check serum glucose,
hemoglobin a1c, and urine ketones to investigate an
undetected diabetes mellitus (strong recommenda-
tion based on low-quality evidence, 1C).
In patients with suspected Fournier’s gangrene, we
suggest to use Laboratory Risk Indicator for Necrotis-
ing Fasciitis (LRINEC) score for an early diagnosis
and Fournier’s Gangrene Severity Index (FGSI) for
prognosis and risk stratification (weak recommenda-
tion based on moderate quality evidence, 2B).
Perineal necrotizing fasciitis, also called Fournier’s
gangrene, is a rare and potentially life-threatening necro-
tizing infection involving the fascia and subcutaneous
tissues of the external genitalia or perineum [50], with
potential manifestations that may include septic shock
and multiple organ failure. Debate on the precise defin-
ition of this condition is still ongoing, but the most com-
monly accepted was proposed by Smith et al. As “an
infective necrotizing fasciitis of the perineal, genital, or
perianal region” [51]. A large population-based epi-
demiological study from the USA [52] found an overall
incidence of 1.6 Fournier’s gangrene cases per 100,000
males annually, accounting for less than 0.02% of all
hospital admissions. Males are predominantly affected,
with a male to female ratio of 42:1. The mean age of
presentation is 51 years. Mortality rates reach 88% in
some studies, but Sorensen and colleagues report a mor-
tality rate of 7.5% [52]. Patients affected tend to have co-
morbidities, with diabetes and obesity the most
frequently associated pathologies, but all those condi-
tions that result in an impaired host resistance from re-
duced cellular immunity (i.e., alcoholism, HIV,
leukemia) are associated with increased risk of Fournier’s
gangrene [53]. According to the original description, the
etiology was idiopathic, but the increased knowledge of
this disease has identified three possible sites of origin of
the infection: the perineal skin (24% of the cases), the
colorectal region (21%), and the genito-urinary tract
(19%); an unknown origin still remains for the remaining
36% of the cases [53]. The pathophysiology of the fasci-
itis starts with the presence of a localized infection that
allows the entrance of normally commensal bacteria into
the perineum (the infection is typically polymicrobial,
with Streptococcus, Staphylococcus, and Escherichia coli
commonly present); the subsequent inflammatory re-
sponse results in an obliterative endarteritis, with throm-
bosis of the surrounding vessels and important
reduction in blood flow to this region. The following tis-
sue ischemia promotes further anerobic bacteria prolif-
eration and fascial necrosis and digestion [54]. Diagnosis
is mainly clinical and a focused and detailed medical his-
tory as well as a complete physical examination includ-
ing a careful inspection of the perineum is mandatory.
The most common symptoms of Fournier’s gangrene in-
clude perineal and/or scrotal pain, swelling, and ery-
thema. Pain is usually intense even in the presence of
scarce clinical findings at the perineal examination. Sys-
temic features such as fever and tachycardia are often
present. The examination may reveal purulent discharge,
crepitus (subcutaneous emphysema), and patches of the
necrotic tissue with surrounding edema. Cutaneous
manifestations tend to appear later in the disease process
as these patches progress to florid gangrene [55]. The in-
fection rapidly spreads cranially to the abdominal wall
and caudally to the legs, following the course of the
superficial perineal fascia that is in continuity with Col-
le’s fascia and Scarpa’s fascia. Interestingly, testicular in-
volvement is rare and this has been attributed to their
non-perineal blood supply [54].
The tendency to spread widely and extremely quickly
makes Fournier’s Gangrene a time-sensitive disease:
prompt recognition and treatment are of utmost import-
ance but are not always easy. Several risk scores have
been proposed and the most commonly used are the La-
boratory Risk Indicator for Necrotising Fasciitis (LRIN
EC) [56], the Fournier’s Gangrene Severity Index (FGSI)
[57], and its simplified version (SFGSI) [58]. These
scores seem to be reliable tools for diagnosis and prog-
nosis in Fournier’s gangrene, even if their accuracy is
still a matter of debate.
Regarding the LRINEC, some recent meta-analyses
reach discordant results. The first by Bechar et al. [59]
found a statistically positive correlation between LRIN
EC score and diagnosis of necrotizing fasciitis, defining
the LRINEC score as a useful tool in the diagnosis and
surgical treatment of patients with necrotizing fasciitis.
In 2019, Fernando et al. [60] concluded that, given its
poor sensitivity, LRINEC score should not be used to
rule out a necrotizing soft-tissue infection and that in
case of high clinical suspicion an early surgical consult-
ation is required. In the same year, a third meta-analysis
[61] found a variable range of sensitivity (43.2–80%),
positive predictive value (57–64%), and negative
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predictive value (42–86%)” for the LRINEC and that pa-
tients with higher SOFA score, prolonged ICU and hos-
pital stay, and mortality usually presents with higher
LRINEC scores. More importantly, this meta-analysis
demonstrated the LRINEC score is not sensitive in im-
munocompromised patients. In conclusion, these studies
seem to agree that LRINEC should only be used to con-
firm the diagnosis of necrotizing fasciitis and not to ex-
clude it, due to its poor sensitivity. Confirmation of the
poor sensitivity of LRINEC score comes from a recent
study by Cribb et al. [62]: this retrospective study in-
cluded 138 patients with necrotizing fasciitis and found
a 60% sensitivity for the LRINEC score for differentiating
between cases of necrotizing fasciitis from controls with
severe cellulitis. The authors then proposed a novel
scoring system, the SIARI score (site other than lower
limb, immunosuppression, age < 60 years, renal impair-
ment, inflammatory markers) and stated that the SIARI
score demonstrated superior discriminative ability com-
pared with the LRINEC score in both the developmental
and validation cohorts. However, this scoring system has
not been validated in other studies yet.
FGSI score was developed in 1995 by Laor et al. [57]
specifically for the evaluation of Fournier’s gangrene.
FGSI includes nine clinical/laboratory parameters (i.e.,
temperature, heart rate, respiration rate, serum sodium,
serum potassium, serum creatinine, hematocrit, white
blood count, serum bicarbonate) and remains the most
commonly used scoring system to predict patient mor-
tality, with a reported sensitivity of 65–88% and specifi-
city of 70–100% [63–66]. Most of the studies agree with
the cutoff value set by Laor et al. as patients with a FGSI
>9 have a 75% probability of death [57, 63, 65]. The de-
bate on which scoring system performs best is still on-
going and contrasting results on FGSI’s reliability can be
found in the literature [67, 68]. In 2010, Yilmazlar et al.
proposed a modification, adding age and extent of dis-
ease to the FGSI [69]: the novel scoring system, called
Uludag FGSI (UFGSI), was reported to be superior to
FGSI in predicting patient mortality in one study, but
not in another [66]. Later on in 2014, Lin et al. analyzed
84 patients and compared the parameters of FGSI be-
tween survivors and non-survivors. Based on the results
of this analysis, they generated a simplified FGSI (SFGS
I), including only the parameters that showed a signifi-
cant difference between the two groups (serum creatin-
ine, hematocrit, and serum potassium levels) [58]. The
resulting scoring system provided sensitivity and specifi-
city of 87% and 77% in predicting patient mortality, re-
spectively. This scoring system has been validated in
other studies and showed a good reliability for risk
stratification [70].
In conclusion, there is still no agreement on which
scoring system should be adopted but, based on the
available literature, we can state that early diagnosis
using LRINEC score and stratification of patients into
risk categories using FGSI score (or its modified versions
SFGSI and UFGSI) may help in guiding correct
management.
Regarding laboratory tests, in the light of the above in-
formation, we suggest to start the diagnostic workup of
every patient with suspected FG with complete blood
cell count; serum sodium, potassium, glucose, creatinine,
and magnesium; urea; inflammatory markers (e.g., C-
reactive protein, procalcitonin); and coagulation assess-
ment and lactate.
2.B - in patients with suspected Fournier’s
gangrene which are the appropriate imaging
investigations?
In stable patients with suspected Fournier’s gangrene,
we suggest to consider performing a CT scan (weak
recommendation based on low-quality evidence, 2C).
In patients with Fournier’s gangrene, we recommend
that imaging should not delay surgical intervention
(strong recommendation based on moderate quality
evidence, 1B).
In patients with Fournier’s gangrene and
hemodynamic instability persisting after proper re-
suscitation, we suggest against CT imaging (weak
recommendation based on low-quality evidence, 2C).
Diagnosis of Fournier’s gangrene is mainly clinical.
Plain radiographs, ultrasonography, computed tomog-
raphy (CT), and magnetic resonance imaging (MRI) may
demonstrate gas in the soft tissue planes as well as help
determine the extent of the disease [71]. Evidence of gas
formation is present in nearly half of all patients with
FG and is highly specific (94%). Ultrasonographic find-
ings typically include marked thickening of the scrotal
skin, soft tissue inflammation, collections/abscesses, and
subcutaneous gas [72]. In addition, US can demonstrate
paratesticular fluid, which is seen prior to clinical crepi-
tus, and scrotal contents along with Doppler blood flow
can be examined [73]. As imaging evaluation in patients
with FG may be limited by several factors, including the
presence of concurrent acute renal failure or patient
hemodynamic instability, making transport to the im-
aging department unsafe, bedside and point-of-care
ultrasound have emerged as useful tools for FG diagno-
sis [74, 75]. US has multiple advantages: it can be
promptly performed at the patient’s bedside, can evalu-
ate the scrotal contents, and does not require radiation
or intravenous contrast [72]. For these reasons, US can
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be suggested in cases where a CT scan is not available
or not feasible. Otherwise, a contrast-enhanced CT-scan
plays an important role in diagnosing and planning the
treatment of Fournier’s gangrene, because it has greater
specificity for evaluating disease extent than plain radi-
ography, US, or physical examination alone and may also
identify a potential underlying cause [76]. CT has a sen-
sitivity approaching 90% for the diagnosis of necrotizing
soft tissue infections, in addition to high specificity
(93.3%) [75, 77]. MRI with gadolinium contrast is an ex-
cellent soft tissue imaging modality, but is of limited
value in an emergency setting due to its extended time
of examination and limited access to emergency MRI
scanning in many centers [75]. Furthermore, given the
utmost importance of a timely surgical treatment, im-
aging is not mandatory in treating emergent cases of
Fournier’s gangrene with clinical or hemodynamical im-
pairment and we suggest not delaying surgical treatment
in these patients to obtain any form of imaging.
2.C - in patients with Fournier’s gangrene, what are
the indications for surgical treatment and what is
the appropriate timing for surgery?
In patients with Fournier’s gangrene, we recommend
surgical intervention as soon as possible (strong rec-
ommendation based on low-quality evidence, 1C).
In patients with Fournier’s gangrene, we suggest
planning repeat surgical revisions (exploration and
debridement) according to patient conditions (weak
recommendation based on low-quality evidence, 2C).
In patients with Fournier’s gangrene, we suggest seri-
ated surgical revisions until the patient is free of nec-
rotic tissue (weak recommendation based on low-
quality evidence, 2C).
Fournier’s gangrene is a rapidly spreading disease with
a high mortality rate, especially in cases of delayed treat-
ment. Cornerstones of treatment are represented by
antibiotic therapy, appropriate hemodynamic resuscita-
tion, and emergent surgical therapy, with drainage of
fluid collection and complete debridement of necrotic
tissue. It has been shown that early and aggressive surgi-
cal debridement improves survival and reduces the num-
ber of surgical revisions [78–83]. Thus, surgical
intervention should be performed as soon as possible in
the presence of high suspicion for Fournier’s gangrene
and subsequent surgical revisions should be planned
based on the patient conditions (ideally every 12–24 h).
Surgical revisions should be continued until the patient
is free of necrotic tissue [48].
2.D - in patients with Fournier’s gangrene, what is
the appropriate surgical approach?
In patients with Fournier’s gangrene, we suggest to
remove all the necrotic tissue (weak recommendation
based on low-quality evidence, 2C).
In patients with Fournier’s gangrene, we suggest a
multidisciplinary and tailored approach based upon
the extent of perineal involvement, the degree of fecal
contamination, and the possible presence of sphinc-
ter or urethral damage (weak recommendation
based on low-quality evidence, 2C).
In patients with Fournier’s gangrene, we suggest to
perform orchiectomy or other genital surgery only if
strictly necessary and possibly based on a urologic
consultation (weak recommendation based on low-
quality evidence, 2C).
In patients with Fournier’s gangrene, we suggest
planning the surgical management of early and de-
layed surgical sequelae with a multidisciplinary and
skilled team (weak recommendation based on low-
quality evidence, 2C).
Radical surgery, with complete removal of all visible
necrotic tissue, may be sufficient to treat the infection.
In most severe cases, with deep tissue involvement, or-
chiectomy, colostomy, and percutaneous suprapubic
cystostomy may be considered. Common indications for
colostomy are anal sphincter involvement, fecal incon-
tinence, and continued fecal contamination of the
wound [73]. Fecal diversion via colostomy is obviously
beneficial for wound healing, but carries a potential bur-
den of morbidity (and usually requires a subsequent sur-
gical procedure for stoma closure). Furthermore, a
retrospective study by Ozturk et al. shows that tempor-
ary stoma formation significantly increases healthcare
costs without affecting mortality rates and hospital
length of stay [84]. These authors also suggest to post-
pone the decision regarding stoma creation for at least a
48-h period of observation from the initial surgery, to
allow acute inflammation and edema regression, thus
enabling a correct evaluation of sphincters and perianal
tissues. In the light of the above, a multidisciplinary ap-
proach is needed, with early involvement of general or
emergency surgeons, urologists and intensivists, and
plastic surgeons where available [85]. Alternatively to
colostomy, temporary fecal management system has
been introduced for fecal diversion [86], but its use
should be limited to short periods of time to avoid intra-
rectal damage due to the device itself. Regarding urinary
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diversion, common indications for suprapubic urinary
diversion include extensive penile and perineal debride-
ment, urethral involvement, and periurethral abscesses
[87], although most suggest that urinary catheterization
provides satisfactory diversion [88] utilizing suprapubic
cystotomy only in patients experiencing urethral disrup-
tion or stricture [89]. In conclusion, the decision regard-
ing the need for fecal or urinary diversion and the best
way to achieve them should be made by a multidisciplin-
ary team and should be tailored to the characteristics of
the individual patient.
Negative pressure wound therapy (NPWT) plays an
important role in managing soft tissue infections [90].
NPWT has multiple advantages when compared to trad-
itional dressings: it increases blood supply and encour-
ages migration of inflammatory cells into the wound
region; removes exudate, bacteria, and their products;
and promotes the formation of granulation tissue [86].
The main downside of NPWT for the management of
FG is the frequent involvement of the anal area that re-
quires either a NPWT dressing change after every bowel
movement or a bowel diversion system [91].
Due to the anatomical region involved, disfiguring sur-
gery and sexual dysfunction may be unavoidable due to
the necessarily aggressive surgery and may require sub-
sequent complex genital reconstructive surgery and skin
grafting [92, 93]. Reconstructive surgery goes beyond the
aims of these guidelines, but the complexity of the re-
constructive procedure and the psychological burden for
the patient require a dedicated multidisciplinary team.
2.E - in patients with Fournier’s gangrene, which is
the appropriate antibiotic regimen?
In patients with Fournier’s gangrene, we recommend
starting an empiric antimicrobial therapy as soon as
the diagnosis is suspected (strong recommendation
based on moderate quality evidence, 1B).
In patients with Fournier’s gangrene, we recommend
that empiric antimicrobial therapy should include
cover for gram-positive, gram-negative, aerobic and
anaerobic bacteria, and an anti-MRSA agent (strong
recommendation based on moderate quality evi-
dence, 1B).
In patients with Fournier’s gangrene, we recommend
to obtain microbiological samples at the index oper-
ation (strong recommendation based on moderate
quality evidence, 1B).
In patients with Fournier’s gangrene, we recommend
to base antimicrobial de-escalation on clinical
improvement, cultured pathogens, and results of
rapid diagnostic tests where available (strong recom-
mendation based on moderate quality evidence, 1B).
Proposed regimens
In stable patients
Piperacillin/tazobactam 4.5 g 6-hourly
+
Clindamycin 600 mg 6-hourly
In unstable patients
One of the following antibiotics
Piperacillin/tazobactam 4.5 g 6-hourly
Meropenem 1 g 8-hourly
Imipenem/Cilastatin500 mg 6-hourly
+
One of the following antibiotics
Linezolid 600 mg 12-hourly
Tedizolid 200 mg 24-hourly
Or
Another anti MRSA-antibiotic as
Vancomycin 25–30 mg/kg loading dose then 15–20 mg/
kg/dose 8-hourly
Teicoplanin loading dose 12 mg/kg 12-hourly for 3
doses, then 6 mg/kg 12-hourly
Daptomycin 6–8 mg/kg 24-hourly*
Televancin 10 mg/kg 24-hourly
+
Clindamycin 600 mg 6-hourly
*Approved at the dosage of 4 mg/kg/24 h, it is
currently used at higher dosages
Antibiotic treatment of FG should be prompt and ag-
gressive, starting empiric antimicrobial therapy as soon
as the diagnosis is considered. Initial coverage should be
broad, including for gram-positive, gram-negative, aer-
obic and anaerobic organisms and, based on local epi-
demiology, an anti-methicillin-resistant S. aureus
(MRSA) agent [94]. Microbiological samples must be
sent at the index operation to obtain an antibiogram,
thus allowing modification of the drug regimen based on
the specific cultured pathogens. If inflammatory markers
do not improve, it is mandatory to rule out an alterna-
tive or additional source of infection or a residual area
of gangrene with further surgical exploration advised.
Hyperbaric oxygen therapy may help in treating soft tis-
sue infections [87, 95, 96]. For a detailed discussion of
the management of skin and soft-tissue infections, we
refer to the WSES/SIS-E guidelines [48].
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3) Complicated hemorrhoids (thrombosed,
strangulated, or bleeding)
3.A - in patients with suspected complicated
hemorrhoids, what is the role of clinical
examination and biochemical investigations?
No recommendation can be made regarding the role
of biochemical investigations in patients with sus-
pected thrombosed or strangulated hemorrhoids,
based on the available literature.
In patients with suspected bleeding hemorrhoids, we
suggest to collect a focused medical history and to
perform a complete physical examination, including
a digital rectal examination, to rule out other causes
of lower gastrointestinal bleeding (weak recommen-
dation based on low-quality evidence, 2C).
In patients with suspected bleeding hemorrhoids, we
suggest to check vital signs, to determine hemoglobin
and hematocrit, and to assess coagulation to evalu-
ate the severity of the bleeding (weak recommenda-
tion based on low-quality evidence, 2C). In case of
severe bleeding, we suggest blood typing and cross-
matching (weak recommendation based on very low-
quality evidence, 2D).
The usual presentation of patients with complicated
hemorrhoids is either acute anal pain (also called
hemorrhoidal crisis) or anorectal bleeding. In both cases,
a complete medical history, with a focus on the acute
complaint, and a complete physical examination (com-
prehensive of digital rectal examination) are mandatory
to rule out other possible causes of acute anal pain or
bleeding. This division according to the main complaint
at the ER referral will be used also for the following par-
agraphs on hemorrhoids. There is no literature regarding
the role of biochemical investigations in case of a
hemorrhoidal crisis: in this specific setting, the labora-
tory tests should be performed to exclude other causes
of acute anal pain (i.e., anorectal abscesses, Fournier’s
gangrene, anal fissures). It is easy to understand how im-
portant medical history and physical examination are in
starting and driving the diagnostic process. On the other
hand, patients referring with anorectal bleeding fall
under the bigger category of acute lower gastrointestinal
bleeding (LIGB) and should be investigated to exclude
other causes of bleeding. In these cases, it is crucial to
define the severity of bleeding and to correctly stratify
the risk for every patient. Blood test should include a
complete blood count (CBC), serum electrolytes, blood
urea nitrogen (BUN), creatinine, and the coagulation as-
sessment [97]. Blood type and crossmatch for possible
transfusion of blood components should also be ordered
at the time of initial assessment for patients with signs
of severe bleeding. Multiple risk stratification scores are
described in literature [98–104] and most of them in-
clude vital signs and hemodynamic parameters; presence
of blood at rectal examination; laboratory tests, such as
hematocrit, creatinine, and albumin; presence of comor-
bidities; and use of anticoagulant or antiplatelet drugs.
In conclusion, the diagnostic workup of a patient pre-
senting with hematochezia deriving from suspected
bleeding hemorrhoids should start with the assessment
of vital signs, followed by the collection of an accurate
medical history and a thorough physical examination in-
cluding digital rectal examination; then it should
proceed with the execution of the blood tests necessary
to determine the severity of the bleeding and to correctly
stratify the risk for this patient. It is also advisable to
carry out a pregnancy test with the woman’s consent if
there is any doubt about whether she could be pregnant.
3.B - in patients with suspected complicated
hemorrhoids, which are the appropriate imaging
investigations?
In patients with suspected complicated hemorrhoids,
we suggest to perform imaging investigation (CT
scan, MRI, or endoanal ultrasound) only if there is
suspicion of concomitant anorectal diseases (sepsis/
abscess, inflammatory bowel disease, neoplasm)
(weak recommendation based on low-quality evi-
dence, 2C).
The literature regarding complicated hemorrhoids is
extremely scarce, and none of the studies investigate the
role of imaging techniques in this specific subset of pa-
tients. Acute anal pain is the typical manifestation of
multiple anal diseases, including hemorrhoidal crisis,
anorectal abscesses, and anal fissures. The presence of
an associated anorectal mass may further complicate the
scenario, considering that not only thrombosed and pro-
lapsed hemorrhoids could present as an anorectal mass,
but also condylomas, abscesses, polyps, anorectal pro-
lapse, or anorectal cancer can present in the same way
[105]. Lastly, it is important to remember that acute
complicated hemorrhoids could be the clinical manifest-
ation of a concomitant inflammatory anal and perianal
condition, as demonstrated by the reported incidence of
symptomatic hemorrhoids in patients with inflammatory
bowel disease (IBD) ranging from 3.3 to 20.7% [106].
Therefore, a thorough medical history and a complete
physical examination are key factors to drive the diag-
nostic workup of acute anal pain. Imaging studies should
be considered when there is suspicion of an underlying
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diseases. The only study investigating the role of EUS in
hemorrhoidal disease is from Poen et al. [107] and con-
cluded that hemorrhoids are associated with endosono-
graphic thickening of submucosal tissue, internal and
external anal sphincter, but EUS changes cannot predict
treatment outcome or symptom recurrence. The conclu-
sions of the abovementioned studies regarding imaging
techniques in anorectal abscesses can be extended to
complicated hemorrhoids workup, even if they were not
aimed to analyze specifically the role of imaging in
hemorrhoidal disease; however, the recommendations
are weak.
3.C - in patients with complicated hemorrhoids,
what is the role of endoscopy?
In patients with complicated hemorrhoids, we sug-
gest to perform anoscopy as part of the physical
examination, whenever feasible and well tolerated
(low recommendation based on low-quality evidence,
2C).
In patients with complicated hemorrhoids, we sug-
gest to perform colonoscopy in case of concern for in-
flammatory bowel disease or cancer arising from
patient personal and family history, or from physical
examination (low recommendation based on low
quality evidence, 2C).
Endoscopy has a pivotal role in the diagnosis and
management of LGIB. Most authors recommend the use
of anoscopy in all patients referred with complicated
hemorrhoids [108–110], and this opinion is supported
by multiple studies that highlight the good accuracy of
anoscopy in detecting hemorrhoids and other anorectal
lesions, when compared to flexible endoscopy [111, 112].
However, patients with trombosed and strangulated
hemorrhoids usually experience excruciating anal pain
and therefore it is not possible to perform an accurate
anoscopy in an awake patient in this setting. Anoscopy
could be an option for the evaluation of painless anorec-
tal bleeding, while its application in case of
hemorrhoidal crisis usually requires proper sedation.
The next step is to determine which patients requires a
full colonoscopy; it is extremely important not to blindly
attribute painless rectal bleeding to hemorrhoids, be-
cause it may be a sign of other diseases (i.e., colorectal
cancer, inflammatory bowel disease or other colitis, di-
verticular disease, angiodysplasia) [113]. According to
the American Society of Colon and Rectal Surgeons, fur-
ther endoscopic evaluation is warranted if there is con-
cern for inflammatory bowel disease or cancer arising
from a detailed patient personal and family history, and
from a physical examination which may include
anoscopy/proctoscopy and/or flexible sigmoidoscopy
[109]. Obviously, risk factors include anemia, atypical
bleeding, alteration of bowel habits, preceding weight
loss, and personal and family history of colorectal
cancer or IBD.
3.D - in patients with complicated hemorrhoids,
which is the appropriate pharmacological regimen?
In patients with complicated hemorrhoids, we
recommend non-operative management as the first-
line therapy, with dietary and lifestyle changes (i.e.,
increased fiber and water intake together with
adequate bathroom habits) (strong recommendation
based on moderate quality evidence, 1B).
In patients with complicated hemorrhoids, we
suggest to administer flavonoids to relieve symptoms
(weak recommendation based on moderate quality
evidence, 2B).
In patients with thrombosed or strangulated
hemorrhoids, we suggest the use of topical muscle
relaxant (weak recommendation based on low
quality evidence, 2C).
No recommendation can be made regarding the role
of NSAIDs, topical steroids, other topical agents, or
injection of local anesthetics for complicated hemor-
rhoids, based on the available literature.
Medical and pharmacological therapies are by far the
most widely adopted therapy for complicated hemor-
rhoids and are supported by several studies. A Cochrane
review from 2005 investigated the role of laxatives for
the treatment of symptomatic hemorrhoids and included
seven randomized trials enrolling a total of 378 partici-
pants to fiber or a non-fiber control [114]: meta-analyses
using random-effects models showed that laxatives in
the form of fiber had a beneficial effect in the treatment
of symptomatic hemorrhoids, with the greatest effect in
the reduction of bleeding. The authors warned however
that the risk of publication bias and the moderate quality
of the included studies may limit the strength of the re-
sults of the meta-analysis. Another meta-analysis from
the same author focusing only on fiber intakes versus
non-fiber controls found the same results [115].
The role of flavonoids and phlebotonics has been ex-
tensively studied. Phlebotonics are a heterogeneous class
of drugs, consisting of plant extracts (i.e., flavonoids)
and synthetic compounds (i.e., calcium dobesilate),
mainly used to treat chronic venous insufficiency. Two
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major meta-analyses were performed, the first one in
2006 [116] and the second one, developed by the
Cochrane Collaboration, in 2012 [117]. The latter in-
cluded twenty-four randomized controlled trials: twenty
of these studies (enrolling a total of 2344 participants)
evaluated the use of phlebotonics versus a control inter-
vention, two compared different forms of phlebotonics
with each other, one study evaluated phlebotonics with a
medical intervention, and one study compared the use
of phlebotonics with infrared photocoagulation. Phlebo-
tonics demonstrated a statistically significant beneficial
effect for the outcomes of pruritus, bleeding, bleeding
post-hemorrhoidectomy, discharge and leakage, and
overall symptom improvement. On the other hand, the
benefit for pain, pain scores post-hemorrhoidectomy, or
post-operative analgesic consumption is present but did
not reach statistical significance. Again, the definition of
“symptomatic” hemorrhoids used in these studies is un-
clear and makes it difficult to determine whether the
symptoms are acute or chronic; for these reasons, we
cannot make strong recommendations for an acute care
setting.
Severe anal pain is the most common symptom associ-
ated with acute thrombosed external hemorrhoids; in-
ternal anal sphincter hypertonicity is both deriving from
and causing this excruciating pain. Furthermore, the
spasm of anal sphincter worsens the congestion of the
prolapsed piles. For these reasons, the use of muscle re-
laxant, like topical nitrates and calcium channels antago-
nists, has been proposed for the treatment of
thrombosed hemorrhoids. The role of calcium antago-
nists was studied in 2001 in a prospective randomized
study by Perrotti et al. [118] that enrolled 98 patients
with thrombosed hemorrhoids: the study group (50 pa-
tients) received topical 0.3% nifedipine and 1.5% lido-
caine ointment every 12 h for 2 weeks, while the control
group (48 patients) received only topical 1.5% lidocaine
ointment. The authors found a sharp increase in reso-
lution rate of acute thrombosed external hemorrhoids
after 14 days of therapy with topical Nifedipine (92%
resolution rate in the study group as opposed to 45.8%
in the control group), without observing any systemic
side effect. The small number of enrolled patients obvi-
ously limits the power of this study, but the results are
encouraging. The effects of topical nitrates were ana-
lyzed in another prospective study and showed good re-
sults, but these drugs are burdened by a high incidence
of headache that may limit their use [119].
The role of topical anti-thrombotic is not yet clear.
Only one study focused specifically on the use of topical
anti-thrombotic therapy for acute hemorrhoids and hep-
arin treatment was found to significantly improve heal-
ing and resolution of acute hemorrhoids [120, 121].
However, the small number of patients included in this
study does not consent to make any recommendation
regarding the role of this drugs in the treatment of com-
plicated hemorrhoids.
Steroid cream should be applied for no more than 7
days, and a long-term use should be avoided because of
potential thinning of perianal and anal mucosa and in-
creasing risk of injury [122, 123]. There are no scientific
data evaluating either NSAIDS, cortisone, and its deri-
vates or injection of local anesthetics for the treatment
of complicated hemorrhoids.
3.E - in patients with complicated hemorrhoids,
what is the role of office-based procedures?
No recommendation can be made regarding the role
of office-based procedures (i.e., rubber band ligation,
sclerotherapy, infrared coagulation) in complicated
hemorrhoids, based on the available literature.
The literature regarding the utilization of office-based
procedures (i.e., rubber band ligation, injection sclero-
therapy, infrared coagulation, cryotherapy, radiofre-
quency ablation, laser therapy, etcetera) is significant but
generally heterogeneous and of low quality: the number
of published studies is enormous and the definition of
bleeding or symptomatic hemorrhoids is always unclear.
Regarding sclerotherapy, there are anecdotal reports of
its application in patients with acutely bleeding hemor-
rhoids [124].
For these reasons, there is not enough quality data to
make any recommendation regarding the application of
office-based procedures to manage complicated
hemorrhoids.
3.F - in patients with complicated hemorrhoids,
what are the indications for surgical treatment and
what is the appropriate timing for surgery?
In patients with thrombosed hemorrhoids, we suggest
to base the decision between non-operative manage-
ment and early surgical excision on local expertise
and patient’s preference (weak recommendation
based on low quality evidence, 2C).
In patients with thrombosed hemorrhoids, we suggest
against the use of incision and drainage of the
thrombus (weak recommendation based on low-
quality evidence, 2C).
No recommendation can be made regarding the role
of surgery in patients with bleeding hemorrhoids,
based on the available literature.
Tarasconi et al. World Journal of Emergency Surgery           (2021) 16:48 Page 19 of 45
Despite the high incidence of complicated hemor-
rhoids among the general population, there are only
few studies on the surgical treatment of thrombosed
hemorrhoids and none on bleeding hemorrhoids. Fur-
thermore, the definitions of “thrombosed hemorrhoids,”
“hemorrhoidal crisis,” “prolapsed hemorrhoids,” and
“bleeding hemorrhoids” are multiple and confusing,
and most of the currently available studies focus on
chronic complaints and elective procedures. The evidence
is thus scarce and of low quality, making it extremely diffi-
cult to provide evidence-based recommendations.
Focusing on thrombosed hemorrhoids, the studies com-
paring non-operative management (NOM) and surgery led
to contrasting results. A prospective study from Allan et al.
[125] compared the outcome of urgent hemorrhoidectomy
with conservative treatment for prolapsed thrombosed in-
ternal hemorrhoids and found that conservative treatment
was associated with shorter patient stay and less anal
sphincter damage compared with operative treatment. On
the other hand, other studies suggest that surgery may be
superior to conservative management, but the correct dur-
ation of NOM and the timing for surgery are not known, as
confirmed by the literature research performed by Chan
et al. [126]. Patients treated conservatively will eventually
have a resolution of symptoms, but recurrence rate is high
and there is some evidence that surgical excision may result
in more rapid symptom resolution, lower incidence of re-
currence, and longer remission intervals. Simple incision of
thrombosed hemorrhoids with clot removal used to be a
popular procedure but has been abandoned by most spe-
cialists because of persistent bleeding and the significantly
higher recurrence rates seen. A randomized prospective
study by Cavcić et al. [127] divided 150 patients with
acutely thrombosed hemorrhoids into three different arms:
topical application of 0.2% nitroglycerin, incision and
evacuation of thrombus, and excision of the hemorrhoid;
the analysis of pains scores on day 4 after treatment showed
that thrombus evacuation provided the worst results. An-
other study from Greenspoon et al. [128] retrospectively
reviewed 231 patients who underwent treatment for exter-
nal hemorrhoid thrombosis from 1990 to 2002, of which
51.5% was managed conservatively and 48.5% underwent
surgical treatment. Interestingly, they found a significantly
shorter time to symptom resolution in patients treated sur-
gically (3.9 days vs 24 days), as well as a reduced incidence
of recurrence (6.3% vs 25.4%). In this study, patients were
allowed to choose between excision or conservative therapy
and the authors stated that “the decision to manage pa-
tients surgically reflects both patient and physician prefer-
ence”. Jongen et al. [129] retrospectively analyzed 340
patients undergoing excision of thrombosed external hem-
orrhoids under local anesthesia between 1995 and 2000
and concluded that outpatient excision under local
anesthesia can be safely performed with a low recurrence
and complication rate. On the other hand, Ceulemans et al.
compared results after elective and emergency hemorrhoi-
dectomy and found that early complications, reoperation,
and late anal stenosis were more common after emergency
than elective hemorrhoidectomy [130]. Older work by Eu
et al. confirm the increased rate of late anal stenosis after
emergency hemorrhoidectomy, but found similar results in
terms of recurrence and other complications [131]. A
couple of other studies tried to answer the question of
whether stapled hemorrhoidectomy was comparable to
conventional hemorrhoidectomy for thrombosed hemor-
rhoids. These four studies are prospective and randomized
but are based on small cohorts of patients (maximum 40
patients per arm) [132–135]; their conclusions are similar,
reporting better results after stapled hemorrhoidectomy in
terms of less postoperative pain, shorter operation time and
hospital stay, and earlier return to normal activity.
In conclusion, based on the paucity of available studies
and on the small numbers of patients included, we
believe that hemorrhoidectomy can be beneficial in
selected patients and the decision between NOM and
early surgical excision should be based on physician’s
expertise and patient’s preference; furthermore, we
suggest against the use of incision and drainage of
the thrombus, given the higher incidence of bleeding
and relapse of symptoms. The evidence about stapled
hemorrhoidectomy is scarce and, also given the po-
tential for life-threatening complications of this pro-
cedure in the elective setting [136], we do not make
any recommendation for its application in an acute
care - emergency setting.
This literature review could not identify any data re-
garding the role of surgery for bleeding hemorrhoids, so
we cannot make any recommendations in this setting.
3.G - in patients with complicated hemorrhoids,
what is the role of angiography?
No recommendation can be made regarding the role
of angiography in complicated hemorrhoids, based
on the available literature.
There is growing evidence that angiography and
angioembolization could have a role for the treatment of
hemorrhoids in an elective setting. The reported results
are encouraging [137–140], but there are not enough
data to make any recommendation regarding its applica-
tion to an acute care - emergency setting.
4) Bleeding anorectal varices
4.A - in patients with suspected bleeding
anorectal varices, what is the role of clinical
examination and biochemical investigations?
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In patients with suspected bleeding anorectal varices,
we suggest to collect a focused medical history and
to perform a complete physical examination, includ-
ing a digital rectal examination, to rule out other
causes of lower gastrointestinal bleeding (weak rec-
ommendation based on low-quality evidence, 2C).
In patients with suspected anorectal varices, we sug-
gest to check vital signs, to determine hemoglobin
and hematocrit, and to assess coagulation, to evalu-
ate the severity of the bleeding (weak recommenda-
tion based on low-quality evidence, 2C). In case of
severe bleeding, we suggest blood typing and cross-
matching (weak recommendation based on very low-
quality evidence, 2D).
Anorectal varices (ARV) have been defined as discrete,
dilated, and submucosal veins, extending proximal to the
dentate line and into the rectum. They are a known
complication of portal hypertension and can occur in up
to 89% of patients with the portal pressure above 10
mmhg, although the overall incidence in the general
population is low [141]. Despite this high prevalence,
serious hemorrhage from ARV is uncommon, with sig-
nificant bleeding reported in less than 5% of such pa-
tients, but can be fatal [141]. The presence of ARV is
not directly related to a specific cause of portal hyper-
tension, nor to the grade or extension of other varices
(esophageal or gastric); the only clue to suspect this dis-
ease is the presence of anorectal bleeding in patients
with a history of long-standing or uncontrolled portal
hypertension.
As already mentioned in relation to bleeding hemor-
rhoids, the first assessment of patients with haematoche-
zia should follow the indications for the management of
acute LIGB. In the case of ARV, a correct and thorough
medical history is crucial to suspect this specific disease
and can guide the subsequent diagnostic process. It is
necessary to define the severity of bleeding and to cor-
rectly stratify the risk for every patient. Blood test should
include a CBC, serum electrolytes, blood urea nitrogen,
creatinine, and the coagulation assessment [97]. Blood
type and crossmatch for possible transfusion of blood
components should also be ordered at the time of initial
assessment for patients with signs of severe bleeding.
Furthermore, it is advisable to carry out a pregnancy test
with the woman’s consent if there is any doubt about
pregnancy. The risk stratification strategy is superimpos-
able to what has already been discussed in the bleeding
hemorrhoids section.
4.B - in patients with suspected bleeding anorectal
varices, which are the appropriate imaging
investigations?
In patients with bleeding anorectal varices, we sug-
gest EUS +/- color Doppler evaluation as a second
line diagnostic tool, especially for deep rectal varices
or when in doubt (weak recommendation based on
low-quality evidence, 2C).
In patients with bleeding anorectal varices and
failed detection of bleeding site at endoscopy and
EUS, or whenever EUS is not available, we suggest to
perform contrast-enhanced CT-scan (weak recom-
mendation based on low-quality evidence, 2C).
In pregnant patients with bleeding anorectal varices
and failed US detection of bleeding site, we suggest
to perform MRI angiography, if available and if
allowed by the clinical scenario (weak recommenda-
tion based on low-quality evidence, 2C).
The diagnosis of ARV bleeding can be difficult, espe-
cially when bleeding is massive. Should the diagnosis re-
main open to doubt, even after endoscopy, supplementary
diagnostic procedures can be considered and endoscopic
ultrasound (EUS) can be of great help: multiple studies
showed that EUS can detect deep rectal varices in a large
proportion of patients who do not have identified varices
on routine endoscopy [142] and that EUS is better than
endoscopy in detecting rectal varices (85% vs 45%) and in
determining their number [143]. Furthermore, a series of
studies from Sato and colleagues showed a great benefit
with the implementation of EUS with color Doppler
evaluation: in fact, the color doppler examination shows
precisely the anatomy of the entire rectal venous plexus
(intramural rectal varices, perirectal collateral veins, and
communicating veins between intramural rectal varices)
through color flow images and allows the evaluation of
the hemodynamics of varices calculating the velocity of
blood flow in rectal varices; this latter evaluation helpful
in identifying high-risk group for rectal variceal rupture
(the fastest the blood flow is, the more likely the ARV will
bleed) [144–146].
In case both endoscopy and EUS fail to identify the
bleeding, other imaging investigation could be useful.
Barium enema is now only historical. MRI-venography is
also helpful in assessing patients both pre- and post-
transjugular intrahepatic portosystemic shunt (TIPS)
and in diagnosing other sites of abnormal varices [147].
MRI has multiple downsides, making it at least problem-
atic to perform in an emergency setting: it is not avail-
able in every facility and at every hour and it is a lengthy
investigation in terms of time. For these reasons, CT
scan is a better option in an acute care setting. In 2012,
Moubarak et al. [148] provided a detailed description of
all the possible portosystemic collateral vessels that can
be found in patients with liver cirrhosis using a three-
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dimensional contrast-enhanced CT-scan. Although there
are still limited data in the literature, it is thought that
CT may be able to detect bleeding rates as low as 0.35
ml/min. The overall sensitivity of CT for acute
hemorrhage may be as high as 92% and, unlike other
diagnostic modalities, even in cases where a site of active
extravasation is not identified, CT can potentially iden-
tify other findings to suggest a cause or site of origin for
the bleeding [149]. CT has the advantage of a very quick
acquisition but, given that bleeding from rectal varices is
not truly arterial in nature, active extravasation is almost
never visualized. Nevertheless, the visualization of large
serpiginous veins both surrounding the rectum (pararec-
tal varices) and within the rectal wall itself (rectal vari-
ces) on portal venous phase images can be highly
suggestive; CT has also the ability to rule out other
sources of bleeding and may provide information on the
underlying etiologies of vascular and nonvascular dis-
eases, such as inflammatory or neoplastic lesions. A
retrospective study from Nagata et al. [150] comprised
223 patients emergently hospitalized for LGIB who
underwent early colonoscopy within 24 h from arrival at
the hospital and compared the bleeding source rate de-
tection between two strategies: early colonoscopy follow-
ing urgent CT or early colonoscopy alone. They
interestingly found that the detection rate was higher
with colonoscopy following CT for vascular lesions lead-
ing to more endoscopic therapies and concluded that ur-
gent CT before colonoscopy had about 15% additional
value for detecting vascular lesions compared to colon-
oscopy alone.
4.C - in patients with suspected bleeding anorectal
varices, what is the role of endoscopy?
In patients with suspected bleeding anorectal varices,
we suggest the use of ano-proctoscopy or flexible sig-
moidoscopy as the first-line diagnostic tool (weak
recommendation based on low-quality evidence, 2C).
In patients with suspected bleeding anorectal varices
and high-risk features or evidence of ongoing bleed-
ing, we suggest to perform an urgent colonoscopy
(plus upper endoscopy) within 24 h of presentation
(weak recommendation based on low-quality evi-
dence, 2C).
In patients with suspected bleeding anorectal vari-
ces and risk factors for colorectal cancer or suspi-
cion of a concomitant more proximal source of
bleeding, we suggest to perform a full colonoscopy
(weak recommendation based on low-quality evi-
dence, 2C).
In patients with bleeding anorectal varices, we sug-
gest to use local procedures, such as endoscopic vari-
ceal ligation, endoscopic band ligation, sclerotherapy
or EUS-guided glue injection, to arrest bleeding in
first instance where feasible (weak recommendation
based on low-quality evidence, 2C).
It is extremely important to make a correct differential
diagnosis between hemorrhoids and ARV, but this dis-
tinction can be difficult, especially in case of massive
bleeding. Occasionally, patients may have other causes
of massive bleeding, e.g., solitary rectal ulcer syndrome
or diverticulosis of colon. Thus, a correct diagnosis is es-
sential. At clinical examination with proctoscope or ano-
scope usually ARV are discrete, compressible and
serpiginous submucosal varicose veins that cross the
dentate line and extend cranially into the rectum, while
hemorrhoids are abnormal anal cushions with dilatation
of hemorrhoidal venous plexus that are confined within
the anal canal. Thus, simple clinical examination using a
proctoscope or an anoscope is a valuable method for ac-
curately identifying ARV and some studies have shown
that flexible sigmoidoscopy and colonoscopy are as ef-
fective as anoscopy in diagnosing ARV [151–153]. It is
important to remember that patients with ARV might
have other, more proximal, sources of bleeding and ano-
rectal bleeding presents a clinical dilemma in terms of
associated risk of colorectal cancer (CRC). The estimated
risk of CRC in patients with rectal bleeding has been re-
ported to range from 2.4 to 11%, hence a full colonos-
copy may be necessary to identify such a source [141].
Furthermore, a randomized trial from Laine et al. [154]
showed that up to 15% of patients presenting with ser-
ious hematochezia (defined as alteration of
hemodynamic status, hemoglobin drop ≥1.5g/dl, or ne-
cessity of blood transfusion) have an upper gastrointes-
tinal source of bleeding identified at upper endoscopy.
Another interesting study by Jensen et al. [155] found
that even in a selected cohort of patients with diverticu-
losis and hematochezia, up to 8% of bleedings have an
upper source. We suggest to perform an upper endos-
copy in all cases where a clear diagnosis of bleeding
ARV is not possible.
Endoscopy also has a therapeutic role in these patients
and those with high-risk features or who have evidence
of ongoing bleeding should undergo an urgent colonos-
copy within 24 h of presentation [156]. The use of local
treatment is described in the literature for both control-
ling acute bleeding from ARV and in the secondary pre-
vention of bleeding, but there is no evidence supporting
a prophylactic treatment of asymptomatic ARV. Multiple
techniques have been reported [157–169], but a thor-
ough discussion of the endoscopic approach goes be-
yond the aims of this guidelines.
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4.D - in patients with bleeding anorectal varices,
what is the role of non-operative management?
In patients with bleeding anorectal varices, we sug-
gest multidisciplinary management, early involving
the hepatology specialist team and focusing on opti-
mal control of comorbid conditions (weak recom-
mendation based on very low-quality evidence, 2D).
In patients with anorectal varices and mild bleeding,
we suggest intravenous fluid replacement, blood
transfusion if necessary, correction of coagulopathy,
and optimal medication for portal hypertension
(weak recommendation based on low-quality evi-
dence, 2C).
In patients with anorectal varices and severe bleed-
ing, we recommend to maintain an Hb level of at
least > 7 g/dl (4.5 mmol/l) during the resuscitation
phase and a mean arterial pressure > 65 mmhg, but
avoiding fluid overload (strong recommendation
based on moderate-quality evidence, 1B).
In patients with bleeding anorectal varices, we sug-
gest the endorectal placement of a compression tube
as a bridging maneuver, to help stabilization of the
patient or to allow the transfer to a tertiary hospital
(weak recommendation based on very low-quality
evidence, 2D).
The management of bleeding ARV can be very chal-
lenging and essentially includes prompt resuscitation
and correction of coagulopathy, immediate workup to
localize the site/source of bleeding and then the applica-
tion of a suitable treatment modality or immediate
transfer to a tertiary referral center. Management op-
tions may vary with a combination of local/endoscopic,
medical, radiological, and surgical methods available. In
mild cases, intravenous fluid replacement, blood transfu-
sion, correction of coagulopathy, and optimal medication
for portal hypertension are usually effective.
Initial resuscitation and hemodynamic stabilization are
critical and patients’ conditions should be optimized before
endoscopic intervention. The management of comorbid
conditions, including the appropriate management of anti-
platelet agents and anticoagulants, requires a multidisciplin-
ary and individualized approach.
The intravascular volume repletion is done with crys-
talloids and packed red blood cells. The targets of resus-
citation are the restoration of hemodynamic status but
avoiding over-expansion, which may exacerbate portal
pressure, impair clot formation, and increase the risk of
further bleeding [170]. In fact, a certain degree of
hypovolemia and hypotension promotes activation of en-
dogenous vasoactive systems, leading to splanchnic vaso-
constriction and, therefore, reducing portal blood flow
and pressure. A recent randomized controlled trial
showed that a restrictive packed red blood cell transfu-
sion strategy improves survival in Child–Pugh A and B
patients. The results of this study showed that patients
with cirrhosis and acute variceal bleeding should be
transfused when hemoglobin drops below 7 g/dl, aiming
at a target level of 7–9 g/dl [171]. Other risks related to
blood product utilization are immunologic (transfusion-
related lung injury and development of HLA antibodies)
and can impact subsequent transplantation or impair the
ability to receive further transfusions [172–174]. A re-
cent guideline from the American Gastroenterology As-
sociation (AGA) Institute Clinical Practice Updates
Committee [175] suggests the following transfusion
thresholds for management of active bleeding in ad-
vanced liver disease: hematocrit >25%, platelet count
>50,000, and fibrinogen >120 mg/dl. Exceptions to this
restrictive strategy are massive bleeding, which should
prompt the activation of a dedicated transfusional proto-
col, cardiovascular comorbidities, and any other condi-
tion that precludes adequate physiological response to
acute anemia. It is important to keep in mind that an
acute hypotension may decrease hepatic perfusion,
which in the setting of underlying chronic liver disease
can exacerbate liver injury. A helpful maneuver to slow
down the bleeding rate could be the endorectal place-
ment of a compression tube (i.e., Sengstaken-Blakemore
Tube or a Linton-Nachlas balloon compression tube)
[141, 176–181] held under moderate traction: this device
should be left in place until the patient is sufficiently sta-
bilized or until the patient is transferred to a center with
available expertise. The placement of balloon tamponade
can also give additional time to correctly study the pa-
tients with CT scans or other imaging techniques, thus
enabling to tailor the management strategy to the anat-
omy of the bleeding vessel [182]. Eventually, rebleeding
is almost universal if another modality of treatment is
not instituted.
4.E - in patients with bleeding anorectal varices,
which is the appropriate pharmacological regimen
(including antibiotics)?
In patients with anorectal varices, we suggest the use
of non-selective beta-adrenergic blockers for preven-
tion/prophylaxis of first and/or recurrent variceal
bleeding (weak recommendation based on very low
quality evidence, 2D). In case of acute bleeding, we
suggest to temporarily suspended beta blockers (weak
recommendation based on low-quality evidence, 2C).
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In patients with bleeding anorectal varices, we sug-
gest to consider the use of vasoactive drugs, such as
terlipressin or octreotide, to reduce splanchnic blood
flow and portal pressure (weak recommendation
based on very low-quality evidence, 2D).
In patients with bleeding anorectal varices, we rec-
ommend a short course of prophylactic antibiotic
(strong recommendation based on moderate quality
evidence, 1B).
The aim of medical therapy is to reduce splanchnic
blood flow and portal pressure. Drugs currently in use
are vasopressin, somatostatin, and terlipressin. Concomi-
tant use of vasoactive drugs lowers portal pressure and
potentially offers the endoscopist a clearer field to work
in and it is the only non-invasive treatment for non-
esophagogastric variceal sites of bleeding related to por-
tal hypertension [183]. There are no trials available re-
garding the use of these vasoactive drugs for the
treatment of bleeding ARV, but these drugs are clearly
beneficial when used for acute bleeding from gastro-
esophageal varices and therefore can be considered for
use in bleeding ARV [141]. Vasopressin has a short half-
life and should be given as a continuous iv infusion; fur-
thermore, vasopressin has relevant side effects related to
the important systemic vasoconstriction that could lead
to mesenteric or myocardial ischemia. Therefore, vaso-
pressin is not often used also because Terlipressin, a
synthetic vasopressin analog with a longer half-life and
less adverse effects, is effective in bleeding control and
has a positive impact on survival. Both somatostatin and
octreotide (a synthetic analog of somatostatin with lon-
ger half-life) have a good safety profile, and somatostatin
is as effective as vasopressin in control of variceal bleed-
ing. A literature review by Biecker [147] analyzed all the
studies regarding the use of these drugs for the medical
treatment of acute bleeding from esophageal varices and
concluded that the available data is most convincing for
terlipressin; however, the direct comparison of terlipres-
sin and octreotide revealed no superiority of terlipressin.
All the studies mentioned so far regard bleeding from
esophageal varices, we can try to extend these indica-
tions to the varices of other districts of the body, but the
grade of recommendations is necessarily weak and fur-
ther studies are needed to define the best medical ap-
proach to bleeding ARV.
No trials are available regarding the role of non-
selective beta-blockers and/or nitrates for the treatment
of bleeding from varices other than esophageal or gas-
tric, but non-selective beta-blockers cause vasoconstric-
tion of the splanchnic circulation by β2-receptor
inhibition and decrease cardiac output by β1-receptor
blockade, and this could lead to a decrease in portal
venous inflow and thereby lowers portal pressure [147].
The desired reduction of 20% in the portal pressure gradi-
ent is achieved in about 50 to 75% of patients with pro-
pranolol or carvedilol, respectively [184]. Beta-blockers
have other effects besides the reduction of hepatic venous
pressure gradient, such as the reduction of azygos blood
flow [185, 186] and could therefore be used for the pre-
vention of ARV bleeding. However, it should be kept in
mind that hypotension (systolic blood pressure below 90
mmhg or mean arterial pressure below 65 mmhg) is a
contraindication to the use of beta-blockers. Therefore,
despite their prophylactic role, in the acute setting of a
hypotensive patient with bleeding anorectal varices beta
blockers should be temporarily suspended [184].
The abovementioned AGA guideline [175] also sug-
gests to consider anti-fibrinolytic therapy in patients
with persistent bleeding consistent with impaired clot in-
tegrity. Both ε-amino-caproic acid and tranexamic acid
inhibit clot dissolution reducing hyperfibrinolysis and
can be used as a rescue therapy.
Regarding antimicrobial therapy, multiple meta-
analysis [187–190] showed a clear benefit in terms of
survival and decrease the risk of spontaneous bacterial
peritonitis when a short course of prophylactic treat-
ment is given in all patients presenting with cirrhosis
and gastrointestinal bleeding including rectal bleeding.
4.F - in patients with bleeding anorectal varices,
what is the role for angiography?
In patients with bleeding anorectal varices and fail-
ure of medical treatment and local procedures, we
suggest a “step up” approach with radiological and
then surgical procedures (weak recommendation
based on low quality evidence, 2C).
In patients with bleeding anorectal varices, we sug-
gest to use embolization via interventional radio-
logical techniques for the short-term control of
bleeding (weak recommendation based on low qual-
ity evidence, 2C).
In patients with bleeding anorectal varices and se-
vere portal hypertension, we suggest to use percutan-
eous TIPS, if not contraindicated, to decompress the
portal venous system and to reduce the risk for
rebleeding (weak recommendation based on low
quality evidence, 2C).
No recommendation can be made regarding the
superiority of one embolization technique over the
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others in case of bleeding ARV, based on the avail-
able literature.
Embolization is performed via an interventional radio-
logical approach and could be performed alone or in as-
sociation with a TIPS procedure. The aim of
embolization is to interrupt the communication between
portal and systemic circulation, thus stopping the acute
bleeding; however, this maneuver alone does not decom-
press the portal venous system and this situation lead to
high rebleeding rates [179, 191–194]. The association
with TIPS reduces the rates of rebleeding, decompres-
sing the portal venous system. TIPS has the advantages
of being effective and minimally invasive, it can be per-
formed in one session and does not preclude subsequent
liver transplantation; therefore it may be used during the
acute situation both as a bridge to liver transplantation
and as the definitive therapy in patients unfit for surgery
[195]. The downsides of TIPS are the potential for in-
creased encephalopathy (20–30%), recurrent bleeding
(10%), procedure-related morbidity and a 30-day mortal-
ity of around 3–15% [141, 196]. A novel and interesting
percutaneous approach is the BRTO (balloon-occluded
retrograde transvenous obliteration). Developed by
Kanagawa et al. In 1996 [197] for the management of
gastric varices, the BRTO procedure is an endovascular
technique that causes occlusion of outflow portosyste-
mic shunt using an occlusion balloon followed by the
endovascular injection of a sclerosing agent directly into
the variceal system. This procedure is less invasive than
TIPS and does not affect encephalopathy, but it can
worsen the portal hypertension [198]. Few case series re-
port the application of this technique to the rectum with
good results in terms of hemorrhage control [182, 198].
In 2019, a case report described the combination of
BRTO and TIPS, with satisfactory results [199]. Re-
cently, some authors described a balloon-occluded an-
terograde transvenous sclerotherapy via direct puncture
of the superior rectal vein through the greater sciatic
foramen under CT guidance [200]. All the studies afore-
mentioned are the direct demonstration that the role of
intervention radiological approach is now crucial for the
management of bleeding ARV, relegating surgery to a
backup role in case of radiological failure.
4.G - in patients with bleeding anorectal varices,
what are the indications for surgical treatment and
what is the appropriate timing for surgery?
In patients with bleeding anorectal varices and fail-
ure of medical treatment, local and radiological pro-
cedures, we suggest a “step up” approach with
surgical procedures (weak recommendation based on
low-quality evidence, 2C).
In patients with bleeding anorectal varices and fail-
ure of medical treatment, local and radiological pro-
cedures, we suggest against the use of “per anal”
suture ligation (weak recommendation based on very
low-quality evidence, 2D).
No recommendation can be made regarding the role of
doppler-guided hemorrhoidal artery ligation and sta-
pled anopexy in patients with bleeding anorectal varices
and failure of medical treatment, local and radio-
logical procedures, based on the available literature.
The current evidence supports the use of local proce-
dures to arrest bleeding where feasible, with radiological
or surgical procedures used in the event of failure. Surgi-
cal methods include simple suture ligation, inferior mes-
enteric vein occlusion, and porto-caval shunt surgery,
but most of these patients have poor general condition
and will not tolerate an invasive approach. A small retro-
spective case series by Bittinger et al. [201], analyzing pa-
tients with liver cirrhosis admitted for LGIB, found an
80% mortality within 2 months from bleeding for the co-
hort of patients with bleeding ARV, compared to a 13%
mortality for patients with other sources of LGIB. The
increase in mortality rate was related to hepatic failure
and was not related to the hemorrhage itself. Yoshino
et al. [182] conclude that a favorable prognosis may not
be expected in cirrhotic patients with bleeding rectal
varices, even when initial hemostasis is achieved (cumu-
lative survival rates were 63.6% and 32.7% at 6 and 12
months, respectively) and hypothesized that hemorrhage
may occur in patients with liver cirrhosis at the final
stage during progression of portal hypertension. For
these reasons, inferior mesenteric vein occlusion and
porto-caval shunt surgery are historical, especially with
the advent of percutaneous and radiological procedures.
Direct suture ligation is a technically challenging op-
tion and often not successful. Several authors have suc-
cessfully used running sutures of synthetic absorbable
sutures, but currently, suture ligation is not routinely ad-
vised for ARV because of the high rate of rebleeding and
the difficulty in performing the procedure during active
bleeding [141]. This procedure is reserved for patients
who are unfit for any other procedures and in situations
where no other treatment is available. The direct suture
approach has been replaced in many cases by a stapled
anopexy: the rationale behind this technique is the inter-
ruption of the perirectal porto-systemic anastomosis.
This technique as the advantages of being easy to
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perform and used most colorectal surgeons for other in-
dications, making it an available option for the initial
treatment of refractory bleeding ARV. As reported by
few case-reports and a small case-series, the results are
encouraging and the rebleeding rate is very low [202–
205]. However, stapled anopexy in cases of severe bleed-
ing is hardly feasible and thus cannot be recommended
as first-line option. A case report described the use of
Doppler-guided hemorrhoidal artery ligation for the
treatment of bleeding ARV [206], defining the technique
as feasible and safe; unfortunately, no recommendation
can be made on the base of a single-case report. In con-
clusion, our suggestion is to proceed with a step-up ap-
proach, starting from local endoscopic maneuvers up to
TIPS or even liver transplantation in very selected cases.
5) Complicated rectal prolapse (irreducible or
strangulated)
5.A - in patients with a suspected complicated
rectal prolapse, what is the role of clinical
examination and biochemical investigations?
In patients with suspected complicated rectal pro-
lapse, we suggest to request complete blood count
and the dosage of serum creatinine, and inflamma-
tory markers (e.g., C-reactive protein, procalcitonin
and lactates) to assess the status of the patient (weak
recommendation based on low-quality evidence, 2C)
Rectal prolapse (RP) can be defined as a circumferen-
tial, full-thickness intussusception/protrusion of the rec-
tum through the anus. These guidelines will address
only full-thickness prolapses (true or Type III) which is
a complete protrusion of the rectum (and/or the sig-
moid) with its entire wall through the anus [207].
An incarcerated RP corresponds at clinical examin-
ation to an external, complete RP associated with a large
rectal mass or bulge that cannot be reduced manually
(large, painful, immobile rectal mass). When the blood
supply to the prolapsed bowel is not sufficient then the
RP may become strangulated and can quickly progress
to necrosis and perforation. A complete RP is a rare
condition and is usually seen in extremes of life and
more commonly in females [207]. In fact, the incidence
of RP is approximately 2.5 per 100000 inhabitants, with
a prevalence of 1% in adults over 65 years, with a
women:men ratio of 9:1 [208]. Incarceration and stran-
gulation are rare but serious and life-threatening condi-
tions requiring prompt surgical consultation and
treatment.
Rectal prolapse is generally diagnosed on the basis of
patient’s full history, symptoms, and clinical examin-
ation. In clinical practice, it is essential to make
differential diagnosis with prolapsed haemorrhoids: RP
involves a concentric protrusion whereas prolapsed
hemorrhoids are radial bulging and prolapse of discrete
anal cushions. Patients admitted to ED presenting
chronic or acute rectal prolapse usually complain of
lower abdominal pain, constipation, and hematochezia.
When a patient is admitted with a suspected diagnosis
of RP, the medical history followed by a careful physical
examination are usually enough to confirm the diagno-
sis. The decision to perform laboratory tests to assess
the severity of illness should be guided by the physical
examination.
Leukocytosis is usually present in patients with bowel
ischemia, except in those who are immunocompromised
or taking steroids, and it can be considered a potential
predictor for transmural bowel necrosis, as well as a sig-
nificant predictor of mortality in patients with acute
mesenteric ischemia. Inflammatory biomarkers such as
C-reactive protein (CRP), procalcitonin (PCT), and lac-
tate are the most prescribed lab tests in the emergency
department to evaluate the severity of the disease in case
of Acute Abdomen (AA). Lactates level is a marker of
poor tissue perfusion, a key element in the management
of severe sepsis, septic shock, and bowel ischemia [209].
Another important test is PCT: it is known that its
values are significantly correlated with intestinal necrotic
damage, degree and extension of tissue damage, and
mortality [210, 211]. Furthermore, there are different
studies highlighting a potential role for interleukin-6
(IL-6) in the diagnostic workup of AA: it seems that its
use, in combination with serum lactate, could be useful
in simultaneously establishing both the severity of sepsis
and the prognosis of AA [212]. In the case of a female
patient of childbearing age presenting with rectal pro-
lapse, it could be advisable to consider the dosage of β-
HCG to exclude pregnancy.
5.B - in patients with a suspected complicated
rectal prolapse, which are the appropriate imaging
investigations?
In hemodynamically stable patients with irreducible
or strangulated rectal prolapse, we suggest to per-
form an urgent contrast enhanced abdomino-pelvic
CT-scan, whenever available and without delaying
appropriate treatment, to detect possible associated
complications and to assess the presence of a colorec-
tal cancer (weak recommendation based on low-
quality evidence, 2C).
In hemodynamically unstable patients with irredu-
cible or strangulated rectal prolapse, we suggest
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against delaying appropriate and timely manage-
ment to perform imaging investigations (weak recom-
mendation based on low quality evidence, 2C).
After assessing patient’s hemodynamic status, a con-
trast enhanced abdomino-pelvic CT scan should be per-
formed to investigate potential conditions associated
with complicated RP [213–216], such as acute bowel ob-
struction, signs of perforation and peritonitis, prolapse
of other pelvic organs (uterus, vagina and/or bladder,
sigmoid colon, small bowel) [217], and to rule out the
presence of colorectal malignancy. A sudden RP could
be the first clinical manifestation of a colon cancer, as
demonstrated by several case reports [218–221]; there-
fore, multiple authors suggest that patients with rectal
prolapse should have endoscopic examination of the
colon and rectum. Akyuz et al. hypothesized that the age
group in which RP is most commonly seen, the change
in bowel habits, the chronic constipation, and mucosal
irritation related to this disease, could be the factors that
increase the incidence of rectum cancer in patients with
RP and concluded that endoscopic screening should not
be overlooked in this specific population [222]. An inter-
esting retrospective study from Rashid et al. [223] com-
pared data from 70 consecutive patients treated for RP
and 350 patients of similar age treated for other condi-
tions at a community hospital during a period of 16
years with an average follow-up of 4.4 ± 2.7 years. They
reported a rectosigmoid cancer prevalence of 5.7%
among patients with RP compared to a prevalence of
only 1.4% in the control group. Thus, patients with RP
exhibited a relative risk for colorectal cancer increased
by 4.2-fold (95% confidence interval, 1.1 to 16.0, p <
0.02) and the authors concluded that a routinely screen-
ing of patients with symptomatic RP by use of flexible
sigmoidoscopy may be appropriate.
The findings of the CT scan can guide the choice be-
tween NOM and surgery and of the best surgical approach
(perineal vs. abdominal), thus reducing the risk of leaving
a possible complication undetected and untreated. On the
other hand, CT scan may not be promptly available in
every facility, and a timely management of strangulated
rectal prolapse is of utmost importance. For these reasons,
the decision whether to perform a CT scan should be
made based on patient clinical condition and on the avail-
able resources and should not delay the appropriate man-
agement of complicated rectal prolapse.
5.C - in patients with complicated rectal prolapse,
what which is the role of non-operative management?
In patients with incarcerated rectal prolapse without
signs of ischemia or perforation, we suggest to
attempt conservative measures and gentle manual
reduction under mild sedation or anesthesia (weak
recommendation based on moderate quality evi-
dence, 2B).
In hemodynamically unstable patients with compli-
cated rectal prolapse, we suggest against delaying
surgical management to attempt a conservative
management (weak recommendation based on low
quality evidence, 2C).
Non-operative management (NOM) in incarcerated
RP aims the following:
– Reduce the edema;
– Allow manual reduction;
– Plan an elective definitive surgery in optimal
patient’s conditions.
For irreducible RP without signs of ischemia, gentle
manipulation and reduction with patient in Trendelen-
burg position and under intravenous sedation and
analgesia is an attempt of deferring surgery to an elective
setting. Every effort should be made to manually reduce
an incarcerated RP in order to avoid complications such
as strangulation, ulceration, bleeding, and perforation.
NOM is not indicated in case of strangulated RP with
signs of gangrene or perforation and in a
hemodynamically unstable patient.
The techniques for NOM described in literature are as
follows:
– The submucosal adrenaline injections;
– The topical application of granulated sugar [224].
Topical application of sugar is the most used
technique because it is an easy and accessible
technique to reduce edema and facilitate manual
reduction of RP; the rationale behind this
technique is the creation of an hyperosmolar
environment that attracts water molecules, thus
reducing the edema of the prolapsed bowel.
Unfortunately, the overall efficacy of this
technique is low.
– The topical application of hypertonic solutions of
sugar consisting of 50% dextrose or 70% mannitol
directly to the rectal mucosa by gauzes; it is based
on the same mechanism of the application of sugar
or salt.
– The submucosal infiltration of hyaluronidase [225],
which is an endoglucosidase that acts by
depolymerizing hyaluronic acid causing a
decomposition of the extracellular matrix. This
mechanism allows the fluid collected in the third
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space to drain through the microscopic spaces
created in the extracellular compartment thereby
decreasing edema.
– The elastic compression wrap [226]; this technique
consists in an elastic compression band that uses
increased continuous pressure to force the edema
fluid out of the prolapse. This type of elastic band is
often stored in operating rooms for use in
orthopedic procedures and is easily accessible.
All the NOM technique should be performed with the
patient in Trendelenburg position and after administra-
tion of analgesia or under mild sedation and anesthesia.
The failure rate of NOM reported in the literature for
incarcerated RP is high [227], and therefore, NOM
should not delay surgical treatment. Surgery should be
performed when NOM fails and manual reduction is not
successful, to avoid ischemia and perforation.
5.D - in patients with complicated rectal prolapse,
what are the indications for surgical treatment and
what is the appropriate timing for surgery?
In patients with complicated rectal prolapse and
signs of shock or gangrene/perforation of prolapsed
bowel, we recommend immediate surgical treatment
(strong recommendation based on high quality evi-
dence, 1A).
In patients with complicated rectal prolapse and
bleeding, acute bowel obstruction or failure of non-
operative management, we suggest urgent surgical
treatment (weak recommendation based on low
quality evidence, 2C).
Immediate surgical intervention is reserved for those
patients who present with incarcerated RP complicated
by gangrene, perforation, or signs of shock. An urgent
surgical intervention is indicated for patients with incar-
cerated RP associated with ulceration, bleeding, or acute
bowel obstruction and failure of NOM.
There is no high-quality evidence in literature regard-
ing the correct timing for surgical intervention after
NOM failure. Again, multiple case reports highlight the
relevant rate of NOM failure, delaying the surgical treat-
ment from 4 h to 7 days from onset of symptoms [227–
229]. The evidence though is not sufficient to make spe-
cific recommendations on surgical timing, except for
cases with overt gangrene/perforation/shock where sur-
gery should not be delayed.
5.E - in patients with complicated rectal prolapse,
what is the appropriate surgical approach?
In patients with complicated rectal prolapse and no
signs of peritonitis or hemodynamic instability, we
suggest to base the decision between abdominal and
perineal procedures on the specific patient’s charac-
teristics and on surgeon’s skills and expertise (weak
recommendation based on moderate quality evi-
dence, 2B).
In hemodynamically stable patients with compli-
cated rectal prolapse, in case of abdominal ap-
proach, we suggest to base the decision between open
or laparoscopic surgery on patient’s characteristics
and on surgeon’s skills and expertise (weak recom-
mendation based on very low-quality evidence, 2D).
In patients with complicated rectal prolapse and
signs of peritonitis, we suggest an abdominal ap-
proach (weak recommendation based on low-quality
evidence, 2C).
In patients with complicated rectal prolapse and
hemodynamic instability, we recommend an abdom-
inal open approach (strong recommendation based
on low-quality evidence, 1C).
In patients with complicated rectal prolapse under-
going resectional surgery, we suggest to base the deci-
sion between primary anastomosis, with or without
diverting ostomy, and terminal colostomy on the pa-
tient’s clinical condition and on the individual risk
of anastomotic leakage (weak recommendation
based on low-quality evidence, 2C).
The definitive correction of RP is surgical and mul-
tiple operative procedures are described in literature,
each with their own advantages and disadvantages. In
the elective setting, rectal prolapse surgical repair can be
performed either through the anus (perineal approach)
or through the abdomen; severity of symptoms, patient’s
fitness and preferences are important factors to take into
account while choosing an approach for an individual
patient. Up to now, there is no proven superior tech-
nique and the various techniques can be classified based
on the approach in perineal or abdominal techniques.
The perineal techniques are as follows:
– Anal encirclement (Thiersch procedure)
– Mucosal sleeve resection (Delorme’s procedure)
– Perineal proctosigmoidectomy (Altemeier’s
procedure)
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The abdominal procedures can be performed via either




 Rectopexy with posterior fixation and anterior
mesh sling (Ripstein’s procedure)
 Rectopexy with posterior fixation and posterior
mesh sling (Wells’ procedure)
 Rectopexy with ventral fixation and double
anterolateral mesh sling and modified ventral
rectopexy (Orr-Loygue’s procedure)
– Resection rectopexy with or without mesh.
The debate about the optimal approach continues. To
date, there is no agreement in literature whether the ab-
dominal approach is better than the perineal one, or
vice-versa. In clinical practice, in elective or emergency
setting, the choice of surgical technique depends on the
following:
– The patient's age and surgical risk;
– Coexisting functional symptoms (including
incontinence or constipation);
– Surgeon’s familiarity with a particular surgical
approach.
To our knowledge, there is no high-quality evidence
regarding the best surgical approach in an emergency
setting; the available data derives only from studies per-
formed in the elective setting.
The PROSPER study [230], carried out by Senapati
et al., was aimed to put an end to the debate by compar-
ing the different procedures in the elective setting. Two
hundred ninety-three patients were recruited and ran-
domized between abdominal and perineal surgical ap-
proaches. Recurrence rates were high, but not
significantly different in any comparison. The authors
concluded that no significant differences were seen in
any of the randomized comparisons, although substan-
tial improvements from baseline in quality of life were
noted following all procedures.
The PROSPER study was conceived after an online
survey. After its publication, a further online survey
(“Life after PROSPER” study) was conducted to assess if
in clinical practice something was changed in the man-
agement of patients affected by RP. Interestingly, the
numbers of surgeons favoring a perineal approach de-
creased (18.3% vs 36.5%) although the use of a perineal
procedure in elderly or unfit patients was unchanged
(38.5% vs 37.9%). The survey showed that the surgical
management of external RP had changed and more sur-
geons favored a laparoscopic abdominal approach [231].
A 2015 Cochrane systematic review [232] analyzed 15
RCTs for a total of 1007 patients, to assess the optimum
surgical treatment for full-thickness RP: this study
showed a lack of high-quality evidences together with
the small sample size of the included trials and their
methodological weaknesses. The authors concluded de-
claring the impossibility to identify clinically important
differences between the alternative surgical operations
and highlighting the limit of their review for guiding
practice.
In 2017, Emile et al. carried out a systematic review
[233] aimed to assess the outcomes of the perineal resec-
tional procedures, including Altemeier procedure (AP),
Delorme procedure (DP), and perineal stapled prolapse
resection (PSR), for the treatment of complete RP. They
found that perineal resectional procedures were followed
by a relatively high incidence of recurrence, yet an ac-
ceptably low complication rate, and the authors con-
clude that the superiority of any procedure cannot be
reached due to the significant heterogeneity of the
studies.
Another recently proposed option is a combined ap-
proach (laparoscopic-assisted perineal sigmoid resection
with colo-anal anastomosis); Al-Ameen et al. Described
this technique in a case report and highlighted the role
of laparoscopy in Altemeier’s procedure for strangulated
prolapse: laparoscopy allows an appropriate assessment
of sigmoid length, a proper colonic mobilization, and as-
sures that all redundant bowel is excised. They con-
cluded that this approach could therefore reduce
recurrence rate and need of further surgical interven-
tions [234].
The only data concerning the surgical management of
complicated, complete RP in emergency setting can be
extrapolated from case series [235–241]. Every approach
has advantages and disadvantages that should be taken
into account:
– In emergency setting, perineal procedures can be
performed under spinal anesthesia and are
associated with lower operative morbidity and
mortality (included a lower rate of damage to nerve
plexus and of related sexual dysfunctions) but with
higher recurrence rates than abdominal procedures;
furthermore, perineal procedures require a specific
set of skills and expertise. For these reasons, the
perineal approach could be a feasible option for
elderly or medically unfit patients when appropriate
skills and expertise are available.
– Abdominal approaches have the benefit of entering
the abdominal cavity, thus are the best choice in
case of patients with associated peritonitis [238,
242]. Hartmann’s procedure can be an option in
case of patients with rectal incontinence and in
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patients with signs of sepsis; moreover, Hartmann’s
procedure can be safely performed by emergency
general surgeons.
It is important to remember that when a colo-rectal or
colo-anal anastomosis is performed, the creation of a di-
verting loop colostomy or ileostomy can be an option in
case of increased risk of anastomotic leakage, especially
in the emergency setting. In some cases, an end colos-
tomy could be an alternative, and potentially safer,
option.
5.F - in patients with complicated anorectal
prolapse, which is the appropriate pharmacological
regimen (antibiotics, pain-control, others)?
In patients with strangulated rectal prolapse, we
suggest to administer empiric antimicrobial therapy
because of the risk of intestinal bacterial transloca-
tion; the appropriate regimen should be based on the
clinical condition of the patients, the individual risk
for MDRO, and the local resistance epidemiology
(weak recommendation based on low-quality evi-
dence, 2C).
According to WSES guidelines for management of
intra-abdominal infections (IAI), judicious use of antimi-
crobials is an integral part of good clinical practice. This
approach minimizes the risks associated with the selec-
tion of resistant pathogens. In critically ill patients, anti-
microbial therapy should be started as soon as possible.
In these patients to ensure timely and effective adminis-
tration of antibiotics, always consider the pathophysio-
logical status of the patient as well as the
pharmacokinetic properties of the employed antibiotics.
In patients with uncomplicated IAI, where the source of
infection is treated definitively, post-operative antibiotic
therapy is not necessary. In patients with complicated
IAI undergoing an adequate source-control procedure, a
short course of antibiotic therapy (3–5 days) is always
recommended. Patients who have ongoing signs of peri-
tonitis or systemic illness (ongoing infection) beyond 5
to 7 days of antibiotic treatment, warrant a diagnostic
investigation. The choice of empiric antibiotic regimens
in patients with IAI should be based on the clinical con-
dition of the patients, the individual risk for infection by
resistant pathogens, and the local resistance epidemi-
ology. The regimen will be adapted to intra-operative
cultures that allow expansion of the antimicrobial regi-
men if the initial choice is too narrow and to perform a
de-escalation if the empirical regimen is too broad.
When a microorganism is identified in clinical cultures,
antimicrobial susceptibility testing should always be
performed and reported to guide antibiotic therapy
[49].
In the specific setting of complicated RP, the presence
of strangulation or intestinal obstruction increases the
risk of bacterial translocation and therefore an empiric
antimicrobial therapy is suggested. After proper conser-
vative management of incarcerated RP, there is no indi-
cation for antibiotic therapy, in absence of signs of
systemic infection. In case of NOM failure and surgical
treatment of RP, the antimicrobial therapy should be re-
evaluated after surgery to decide, based on the intra-
operative findings, whether it should be continued, dis-
continued, implemented, or de-escalated. Patients can
also present with RP and peritonitis or sepsis/septic
shock: in these cases, a proper and timely antimicrobial
therapy is of utmost importance. For a throughout dis-
cussion of antimicrobial therapy in patients with IAI, we
refer to WSES guidelines for management of intra-
abdominal infections [48, 49].
6) Retained anorectal foreign bodies
6.A - in patients with suspected retained
anorectal foreign body, what is the role of
clinical examination and biochemical
investigations?
In patients with suspected retained anorectal foreign
body, we suggest to collect a focused medical history
and to perform a complete physical examination (weak
recommendation based on low-quality evidence, 2C).
In patients with suspected retained anorectal foreign
body, we suggest to perform digital rectal examin-
ation after the acquisition of an abdomen X-ray,
whenever possible, to prevent accidental injury to the
surgeon from sharp objects (weak recommendation
based on low-quality evidence, 2C).
In patients with suspected retained anorectal foreign
body and no signs of bowel perforation, we suggest
against routinely requesting of laboratory tests (weak
recommendation based on very low-quality evidence,
2D).
In patients with suspected retained anorectal foreign
body and no signs of bowel perforation, we suggest to
request the routine preoperative blood tests only in
case manual extraction fails/is not feasible (weak
recommendation based on very low-quality evidence,
2D).
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In patients with suspected retained anorectal foreign
body and coexisting suspected bowel perforation, we
suggest to request complete blood count, the dosage
of serum creatinine, and inflammatory markers (e.g.,
C-reactive protein, procalcitonin, and lactates) to as-
sess the status of the patient prior to surgery (weak
recommendation based on low-quality evidence, 2C).
Anorectal foreign bodies (AFB) are seen regularly in
most large hospitals but precise epidemiological data are
not available, because most of the time they are underre-
ported. Anal erotic stimulation is by far the most com-
mon cause of retained AFB, followed by assault,
accidental or iatrogenic events, ingestion of animal
bones and foreign bodies, psychiatric diseases, drug traf-
ficking, and self-treatment of fecal impaction in elderly
people or prostate massage [243–245]. The male preva-
lence of retained AFB is striking, with a male to female
ratio up to 37:1 [246–248]. The majority of patients are
in their thirties [249–251], and AFB are very uncommon
in children and are usually the result of assault or child
abuse, which must be carefully and fully investigated
[244, 251]. There is no limitation to the variety of ob-
jects found retained into the rectum [245, 252–254]:
truncheon/baton, light bulbs, bottles, body spray cans,
sex toys, toothbrushes, drugs, cell phones, fruits,
vegetables, etc.; the wide variety of objects leads to
different clinical presentations related to different
degrees of damage to local tissues of the rectum and
distal colon.
Typically, the hospital admission is delayed, due to the
embarrassment of these patients and their effort to re-
move the object at home [251]; furthermore, in up to
20% of cases, patients will not initially refer to the
retained AFB as the chief complaint [248]. Common
complaints include rectal or abdominal pain, constipa-
tion or obstipation, bright red blood per rectum, or in-
continence [255]. Given these issues, a high index of
suspicion is required to accurately diagnose this condi-
tion, as well as the utmost degree of professionalism. Ini-
tial evaluation should be based on the patient’s history
and physical examination; physical examination should
firstly assess for the presence of peritonitis and clinical
signs such as tachycardia, fever, and hypotension
that should not be underestimated. Digital rectal exam-
ination is a crucial part of physical examination and pro-
vides useful information on the position of the object
and the extent of local injury; however, digital rectal
examination should be performed carefully and possibly
after the acquisition of an abdomen X-ray, to prevent ac-
cidental injury to the surgeon from sharp objects [256,
257]. All findings collected during physical examination
should be accurately reported (external aspect of the
perianal area, presence of abrasions or bruising, status of
the anal sphincter) because are necessary to investigate
an alleged sexual assault. When these first steps do not
suggest the presence of a perforation, routine laboratory
exams are unnecessary, except in those cases requiring
extraction under spinal or general anesthesia.
As covered in the complicated RP section, in case
of suspected bowel perforation, the request of CBC
and the dosage of serum creatinine, and inflammatory
markers (e.g., C-reactive protein, procalcitonin and
lactates) is useful to assess the general status of the
patient [258]. Furthermore, serum toxicology is
mandatory in cases of use or concealment of illicit
drugs.
6.B - In patients with a suspected retained
anorectal foreign body, which are the appropriate
imaging investigations?
In patients with suspected retained anorectal foreign
body, we recommend lateral and anteroposterior
plain X-ray film of the chest, abdomen, and pelvis to
identify the foreign body position and determine its
shape, size, and location and the possible presence of
pneumoperitoneum (strong recommendation based
on moderate quality evidence, 1B).
In hemodynamically stable patients with suspected
retained anorectal foreign body and a suspected per-
foration, we recommend a contrast-enhanced CT
scan of the abdomen (strong recommendation based
on moderate quality evidence, 1B).
In patients with retained anorectal foreign body and
hemodynamic instability, we suggest against delay-
ing surgical treatment to perform imaging investiga-
tions (weak recommendation based on low-quality
evidence, 2C).
Radiography is the major modality used in initial and
follow-up imaging of foreign bodies. When foreign bod-
ies are evaluated on radiographs, it is important to re-
member that they have different radiopacity and
radiographic visibility, related to the X-ray attenuation
characteristics of the object, its surrounding structures,
and the overlying and underlying structures [257]. A
biplanar plain X-ray of the chest, abdomen, and pelvis
can detect the majority of retained AFB and gives useful
information regarding the number, size, shape, location,
and orientation of the foreign bodies [248, 259, 260] and
possible presence of pneumoperitoneum. The plain X-
ray could help predict the cases in whom transanal
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extraction is likely to be unsuccessful: in fact, the dis-
tinction between high- or low-lying retained objects, the
latter being usually amenable of manual extraction in
the ED, can be usually achieved with abdominal X-rays
[249, 261]. However, non-visualization of any object on
X-rays does not rule out the presence of retained AFB,
because some foreign bodies have very low radiopacity
and radiographic visibility. A contrast-enhanced CT scan
is usually the next step and is helpful in locating non-
radiopaque objects, in case of suspected bowel-free per-
foration or abscess or in the diagnosis of bowel obstruc-
tion; in fact, CT scan allows to evaluate not only the
foreign body but also its related complications [257]. In
case a CT scan is not available, erect or lateral decubitus
chest radiographs can be performed to evaluate the pres-
ence of pneumoperitoneum. Erect and left lateral de-
cubitus X-rays have similar diagnostic accuracy, the
latter being better tolerated by patients presenting with
peritonitis. Water-soluble contrast enema is another
valuable option in case of unavailability of CT scan and
can be used to evaluate complications such as rectal per-
foration or fistula [257]. “Point-of-care” ultrasound could
also detect free intra-peritoneal, when performed by a
trained operator, but it is highly operator dependent and
some ultrasound machines have low-quality images; fur-
thermore, sonography has low reliability in obese patients
and in case of subcutaneous emphysema [262]. For these
reasons, its role in the diagnostic workup of AFB still
needs to be defined. Some authors also advocate the exe-
cution of a repeated plain film of the abdomen after the
extraction process, to ensure that no perforation took
place [243, 263]. Given the low sensitivity of the plain X-
ray for the detection of pneumoperitoneum, this routine
use of repeated radiograph can even be deleterious in case
of false negative findings.
6.C - in patients with retained anorectal foreign
body, what is the most appropriate interventional
approach (manual extraction vs endoscopy vs
surgery)?
In patients with low-lying retained anorectal foreign
body without sign of perforation, we suggest an at-
tempt of bedside extraction as the first-line therapy
(weak recommendation based on low-quality evi-
dence, 2C).
No recommendation can be made regarding the
superiority of one trans-anal extraction technique
over the others in case of retained anorectal foreign
body, based on the available literature.
In patients with retained anorectal foreign body and
failure of bedside extraction, we suggest pudendal
nerve block, spinal anesthesia, intravenous conscious
sedation, or general anesthesia to improve chances of
transanal retrieval (weak recommendation based on
low-quality evidence, 2C).
In patients with retained high-lying anorectal foreign
body (above rectosigmoid junction), we suggest an at-
tempt of endoscopic extraction as the first-line ther-
apy (weak recommendation based on low-quality
evidence, 2C).
In patients with retained anorectal foreign body and
suspect of drug concealment, we suggest against any
maneuver that can disrupt the drug package, includ-
ing endoscopic retrieval (weak recommendation
based on low-quality evidence, 2C).
In patients with retained anorectal foreign body, we
suggest to perform a proctoscopy or flexible sigmoid-
oscopy after foreign body removal, to evaluate bowel
wall status (weak recommendation based on low-
quality evidence, 2C).
In patients with retained anorectal foreign body and
signs and hemodynamic instability or perforation,
we recommend against transanal extraction (strong
recommendation based on low-quality evidence, 1C).
The treatment of a retained AFB depends firstly on
the patient’s clinical situation: if peritonitis or signs of
pneumoperitoneum are present any attempt of bedside
extraction is contraindicated and the patient should
undergo urgent surgical exploration, after an initial re-
suscitation with intravenous fluids and administration of
intravenous antibiotics; if the patient is unstable, emer-
gent laparotomy should be performed. Other factors that
affect the treatment are the location of the AFB (objects
in the sigmoid colon are more likely to require operative
extraction compared with those in the rectum), the type
of object (shape and size), and the number of objects
[249]. The removal of small, non-sharp, and low-lying
AFBs can be performed safely in the ED, while bigger,
sharp, or high-lying AFBs requires a prompt referral to
the specialist surgical team to warrant a safe extraction
in the OR. The reviews currently available in literature
report that transanal extraction is successful in 60 to
75% of cases [248, 250, 255]. The use of anesthesia (in-
cluding pudendal nerve block, spinal anesthesia, or
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intravenous conscious sedation) helps to relax the patient,
reduces anal sphincter spasm, improves visualization, and
increases the chances of successful transanal retrieval.
Multiple instruments designed for other purposes can be
used for transanal retrieval of AFB, and they can act either
by grasping the foreign body or by scooping it out from
the rectum, but based on the available literature, no rec-
ommendation can be made regarding the superiority of
one instrument/technique over the others [245, 248, 255].
The use of post-extraction procto-sigmoidoscopy is
debated; the rationale behind this further examination is
to check the condition of the bowel wall after the re-
trieval maneuvers and to identify supernumerary AFB or
fragments of the removed AFB. While some studies ad-
vocate that clinical observation is enough in all those
cases where a perforation was not suspected before ex-
traction [249], other authors reported a significant rate
of post-extraction perforations [248] and recommend a
routinely use of endoscopy after AFB extraction [245,
251, 255]. Given the paucity of good quality data and the
relative safety of the endoscopic examination, we cannot
make a strong recommendation, but we suggest the use
of post-extraction endoscopy.
Rigid or flexible sigmoidoscopy should be performed
to visualize and attempt extraction of all the high-lying
AFBs that are out of reach and sight with a manual
transanal approach. Multiple techniques are described in
literature (polypectomy snare, endoscopic grasper or net,
biopsy forceps, guidewire, and balloon dilator [264]), and
the addition of fluoroscopy can be helpful to assist in
the removal of the object. Thus, endoscopy could be
considered “the next-step” after unsuccessful transanal
extraction of low-lying object and for all the high-lying
AFB that are out of reach for manual transanal extrac-
tion. A specific subset of patients who conceal drugs as
retained AFB, the “body packers” [265], require modified
application of these indications and should be managed
with great caution, because in the event of perforation
or damage to the drug package the patient can experi-
ence the life-threatening complications of drug overdose.
For this reason, endoscopic retrieval is contraindicated
by different authors and specialist societies [266–268]. It
is thus important to keep in mind the possibility of en-
countering a drug pack inside the rectum and should
this be the case, every maneuver that can cause the dis-
ruption of the drug package should be avoided. Further-
more, when drug packages are detected in the anorectal
region, a complete survey of the GI tract is required as
many of these are swallowed rather than inserted
retrograde.
6.D - in patients with retained anorectal foreign
body, what are the indications for surgical treatment
and what is the appropriate timing for surgery?
In patients with retained anorectal foreign body and
no signs of perforation, we suggest a surgical ap-
proach in case of failure of transanal extraction
(weak recommendation based on low-quality evi-
dence, 2C).
In patients with retained anorectal foreign body and
no signs of perforation, we suggest a “step-up” surgi-
cal approach, starting with downward milking and
proceeding to colotomy only when milking/transanal
extraction fails (weak recommendation based on
low-quality evidence, 2C).
In patients with retained anorectal foreign body and
no signs of perforation, we suggest a laparoscopic ap-
proach if skills and instrumentation are available
(weak recommendation based on low quality evi-
dence, 2C).
In patients with retained anorectal foreign body and
bowel perforation with limited peritoneal contamin-
ation, we suggest primary suture only in case of
small and recent perforation and if the colonic tis-
sues appear healthy and well vascularized, and an
approximation of perforation edges could be per-
formed without tension (weak recommendation
based on low-quality evidence, 2C).
In patients with retained anorectal foreign body
and bowel perforation, clinically stable and with-
out risk factors for anastomotic leakage, when pri-
mary suture is not feasible, we suggest resection
with primary anastomosis with or without a di-
verting stoma (weak recommendation based on
low-quality evidence, 2C).
In critically ill patients with retained anorectal for-
eign body and bowel perforation, or in selected pa-
tients with extensive peritoneal contamination and
risk factors for anastomotic leakage, we suggest to
perform a Hartmann’s procedure (weak recommen-
dation based on low-quality evidence, 2C).
In patients with retained anorectal foreign body and
hemodynamic instability, we recommend an emer-
gent laparotomy and a damage control surgery ap-
proach (strong recommendation based on moderate
quality evidence, 1B).
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Lake et al. [249] analyzed the predicting factors for op-
erative intervention in case of retained AFB and found
that the only factor that is statistically related to transa-
nal extraction failure is migration of AFB into the sig-
moid colon, that increases the risk of undergoing to
operative intervention by 2.25 fold. After failure of trans-
anal retrieval, the patient should undergo general
anesthesia and a repeated rectal examination under
anesthesia should be attempted, as the complete relax-
ation subsequent to muscular paralysis may allow trans-
anal extraction. If this attempt fails, then surgery is the
following step. However, some authors state that surgery
should be considered as the first-line treatment in case
of high-lying, hard, or sharp-edged objects [269]. Surgery
in stable patients is guided by a step-up approach.
Laparoscopy should be performed to begin with, as it al-
lows to evaluate the contamination of the peritoneal cav-
ity and, in the absence of a perforation, a laparoscopic-
assisted technique can be performed, gently milking
downward the AFB to allow a transanal extraction [253,
270]. Milking can be performed manipulating the object
distally using transmural pressure and, wherever feasible,
is preferred to colotomy. In fact, colotomy should be re-
served to those cases where all the abovementioned pro-
cedures fail. All these maneuvers can also
be accomplished via a midline minilaparotomy, in case
the laparoscopic skills and instrumentation are not avail-
able. The rate of perforation in case of retained AFB is
around 15% [271, 272]. In case of perforation, the surgi-
cal options vary depending on patient’s status, degree of
peritoneal contamination, duration of the perforation,
and status of the bowel walls. A small, fresh perforation
with limited peritoneal contamination can be treated as
a iatrogenic perforation and can undergo primary repair
after retrieval of the foreign object, if the colonic tissues
appear healthy and well vascularized, and an approxima-
tion of perforation edges could be done without tension
[273]. Hartmann’s procedure has been considered the
procedure of choice in patients with generalized periton-
itis; it remains a safe technique for emergency colectomy
in case of diffuse peritonitis, and it is especially useful in
critically ill patients and in patients with multiple co-
morbidities. However, restoration of bowel continuity
after a Hartmann’s procedure is associated with signifi-
cant morbidity and resource utilization and many of
these patients do not undergo reversal surgery,
remaining with a permanent stoma [274, 275]. Given the
absence of high-quality evidence in the specific popula-
tion of AFB, we refer to the trauma literature [276–279]
and to the WSES guidelines for the management of
acute colonic diverticulitis [280] and for the manage-
ment of iatrogenic colonoscopy perforation [281]: we
suggest that a resection with primary anastomosis, with
or without a diverting stoma, may be performed in
otherwise healthy patients, with good tissue quality and
without risk factors for anastomotic leakage, in case a
primary suture is not feasible. On the other hand, Hart-
mann’s procedure is suggested for the management dif-
fuse peritonitis in critically ill patients and in selected
patients with multiple comorbidities and risk factors for
anastomotic leakage (i.e., requirement of vasoactive
drugs, hemodynamic instability, corticosteroid therapy).
In case of unstable patients, an emergent laparotomy is
mandatory and should be guided by the damage control
surgery principles.
6.E - in patients with retained anorectal foreign
body is there a role for antibiotic therapy?
In patients with retained anorectal foreign body, we
suggest against the routine use of antimicrobial ther-
apy (weak recommendation based on low-quality
evidence, 2C).
In patients with retained anorectal foreign body and
signs of hemodynamic instability or perforation, we
recommend broad spectrum antibiotic therapy ac-
cording to the WSES guidelines on intra-abdominal
infections (strong recommendation based on moder-
ate quality evidence, 1B).
Based on the available literature, no data regarding the
role of antibiotics in patients with retained AFB are
available. In the light of the steady increase of antibiotic
resistances globally, we suggest against the use of anti-
microbial therapy for patients without sign of infection
or perforation. For patients with AFB and perforation,
peritonitis, or other septic complications, we refer to
WSES guidelines for management of intra-abdominal in-
fections for further information [49, 282].
7) Acute anal fissure
7.A - in patients with suspected acute anal
fissure, what is the role of clinical
examination and biochemical investigations?
No recommendation can be made regarding the role
of biochemical investigations in patients with typical
acute anal fissure, based on the available literature.
In patients with atypical acute anal fissure, we sug-
gest to collect a focused medical history and perform
a complete physical examination and laboratory
tests based on the suspected associated illness, to
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rule out other causes (weak recommendation based
on low-quality evidence, 2C).
Anal fissure (AF) is a longitudinal tear within the anal
canal that can extend from the dentate line to the anal
verge. The diagnosis of AF commonly occurs in the
third decade of life without any difference among sex
[283]. Approximately 90% of anal fissures are located
posteriorly in the midline, while anterior fissures occur
in 10% of women versus 1% of men [284]. AF are rarely
located laterally in the anal canal or multiple in number.
In these atypical cases, associated diseases such as inflam-
matory bowel disease (IBD), sexually transmitted diseases
(HIV, syphilis, or herpes), anorectal cancer, or tuberculosis
should be ruled out [285, 286]. The exact etiology of AF is
still unknown. Mechanical rauma caused by the passage of
hard stools is not enough to explain their onset and less
than 25% of patients with AF complains of constipation.
Moreover, manometric studies have supported the ische-
mic ulcer theory, with a strong correlation between in-
ternal anal sphincter (IAS) hypertonia and decreased
anodermal vascular blood flow [287].
AF can be divided, temporally and morphologically,
into acute and chronic: acute fissures are superficial,
with well-demarcated edges and last less than 6 weeks;
chronic fissures are characterized by a distal sentinel tag
and a proximal hypertrophied anal papilla with the ex-
posure of the IAS fibers at the base of the AF and symp-
toms for over 6 weeks [288].
The diagnosis of AF is mainly clinical and is based on re-
cent and past medical history, including family history and
complete physical examination. Patients with AF often com-
plain of severe and prolonged anal pain, referred as passing
a “broken glass”, during and after defecation [289]. Other as-
sociated symptoms include spasm and/or intermittent
bleeding with defecation. When the tone of the IAS is too
high, digital rectal examination can be painful and an exam-
ination under anesthesia is indispensable to rule out other
concomitant diseases such as anal abscess or fistula [290].
No recommendation can be made regarding the role of bio-
chemical investigations among patients presenting typical
acute anal fissure or referring similar symptomatology, based
on the available literature. In case of a suspicion but non-
conclusive physical examination, when concomitant diseases
are suspected, laboratory tests should be based on the sup-
posed associated diseases to rule out other causes.
7.B - in patients with suspected acute anal fissure,
which are the appropriate imaging investigations?
No recommendation can be made regarding the use
of imaging investigations in patients with typical
acute anal fissure, based on the available literature.
In patients with atypical acute anal fissure, we suggest
to perform investigations (endoscopy, CT scan, MRI,
or endoanal ultrasound) only in case of suspected
concomitant inflammatory bowel disease, anal or
colorectal cancer or occult perianal sepsis (weak
recommendation based on low-quality evidence, 2C).
Usually, no imaging investigations are necessary at ini-
tial presentation of acute AF. In case of a suspicion but
non-conclusive physical examination, if the fissure cannot
be seen, the diagnosis is unclear, or if there is significant
bright red bleeding in a patient with an increased risk for
colorectal cancer or in patients above 50 years of age or if
there are features suggesting a secondary anal fissure, im-
aging such as endo-anal ultrasound, endoscopy, CT scan,
or MRI, may be required [285, 286]. The choice of the ap-
propriate imaging technique should be driven by the sus-
pected underling disease. Anorectal manometry could be
indicated in patients who have undergone previous sur-
gery, but it is frequently too painful to be performed with
in the emergency setting.
7.C - in patients with an acute anal fissure, what is
the role of non-operative management?
In patients with acute anal fissure, we recommend
non-operative management as the first-line treat-
ment (strong recommendation based on moderate-
quality evidence, 1B).
In patients with acute anal fissure, we recommend
dietary and lifestyle changes, with increased fiber
and water intake (strong recommendation based on
moderate quality evidences, 1B).
In patients with acute anal fissure, we recommend
against the use of manual dilatation (strong recom-
mendation based on moderate quality evidences, 1B).
No recommendation can be made regarding the use
of controlled anal dilatation in patients with acute
anal fissure, based on the available literature.
Initial treatment of anal fissures is medical or non-
operative. There are only few studies concerning non-
operative management in the treatment of acute AF: 50%
of patients will not require further therapy solving the
problem, in 10–14 days, with non-operative measures
such as sitz baths, fiber, and topical agents [291–295].
However, to prevent a recurrence of AF, the combined
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use of dietary and lifestyle changes and medical therapy
are recommended.
The primary goals of AF therapy are to achieve IAS re-
laxation, thus reducing pain and facilitating the healing
process; minimize anal trauma; increase blood flow; and
treat pain. To obtain these results the cornerstones of
NOM are as follows:
 Stool softeners (increased intake of oral fluids, high-
fiber diet or fiber supplements, and bulk forming
laxatives);
 Sphincter muscle relaxers (warm sitz baths, local
application of calcium channel blockers like
Diltiazem or Nifedipine, local application of Nitrates
like Nitroglycerin and Botulinum injection that
determines a temporal paralysis of the anal sphincter
muscle for 2–3 months). As already mentioned
above, the literature regarding acute AF is scarce
and the available data are often mixed with those
regarding chronic AF, and this is especially true
regarding muscle relaxers. Several pharmacological
agents have been used with the purpose of inducing
the so-called chemical sphincterotomy: based on the
pathophysiology of the disease, NO donors (glyceryl
trinitrate) are vasodilator and may support AF heal-
ing; they promote an increase in local blood flow
and reduce IAS tone. On the other hand, calcium
channel blockers (CCB) block slow L-type calcium
channels of vascular smooth muscle cells, thus redu-
cing the IAS tone and promoting an increase in local
blood flow. In a single double-blind, randomized,
prospective trial on 110 patients with chronic AF,
Perrotti et al. [296] demonstrated the effectiveness
of an industrially manufactured ointment (0.3% ni-
fedipine; 1.5% lidocaine). The authors reported a
healing rate of 95% after 6 weeks compared to 16%
of control group (1% hydrocortisone and 1.5% lido-
caine). According to a recent systematic review and
meta-analysis, including 148 trials and 29 different
non-surgical treatments, CCBs (diltiazem or nifedi-
pine) were more effective than glyceryl trinitrate and
with less risk of headache and hypotension [295]. In
particular, CCBs are associated with a healing rate
ranging from 65 to 95% [297, 298] and with a re-
markable cost-effectiveness compared to other non-
operative treatments [299]. Furthermore, consider-
ing the possibility of systemic side-effects and the
similar rates of healing and pain relief [300], the top-
ical use of CCBs is suggested.
 Pain control (see question 7.D).
There is no standard duration of therapy but adminis-
tration for at least 6 weeks is suggested, with pain relief
occurring usually after 14 days [296, 301].
The hypertonicity of internal anal sphincter was his-
torically treated with manual dilatation. This practice
was abandoned [302], due to the high risk of incontin-
ence (temporary and permanent incontinence rates can
reach 30% and 10%, respectively [303, 304]) and the su-
periority of internal sphincterotomy [295, 305, 306].
Nevertheless, lateral internal sphincterotomy has its own
wound-related complications including fistula, bleeding,
abscess, or non-healing wound in up to 3% of patients
[307, 308]. For these reasons, less traumatic, precise,
measurable, and reproducible techniques of anal dilata-
tion were recently designed and introduced into practice:
balloon dilatation and staged dilatation showed healing
rates superimposable to those obtained after internal
sphincterotomy, with complication and incontinence
rates near zero [309–314]. These results were recently
confirmed in a long-term follow-up study [315]. Unfor-
tunately, all the studies cited above are mainly focused
on chronic anal fissures. For these reasons, controlled
anal dilatation could be included in the non-operative
management and could be taken into account before
surgical treatment of chronic anal fissure, but the avail-
able data are not enough to make recommendation in
the acute setting.
7.D - in patients with an acute anal fissure, what is
the appropriate approach for pain control?
In patients with acute anal fissure, we suggest the in-
tegration of topical anesthetics and common pain
killers in case of inadequate pain control (weak rec-
ommendation based on low-quality evidences, 2C).
No recommendation can be made regarding the use
of botulinum injections in patients with acute anal
fissure, based on the available literature.
Adequate pain control is a cornerstone of acute AF
management; the absence of pain helps reducing the
tone of IAS and promotes correct bowel habits, prevent-
ing the excruciating pain associated with defecation. In
fact, analgesics relief the constant reflex spasm of the
anal sphincter and thus reducing local ischemia and en-
hancing fissure healing. Lidocaine is the most commonly
prescribed topical anesthetic for anal fissures, while ad-
ministration of pain killers like paracetamol or ibuprofen
(either oral or parenteral) and/or perianal infiltration of
anesthetics are indicated for patients with severe acute
pain.
The mechanism of Botulinum toxin in striated muscle
is well known: it acts on the presynaptic nerve terminal
of the neuromuscular junction reducing the release of
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acetylcholine [316]. Several studies investigated the role of
Botulinum toxin on AF, demonstrating the effectiveness
in promoting healing of AF refractory to the first-line
treatment with CCB or glyceryl trinitrate. However, there
are still controversies regarding the dose, preparation, and
the site of injection. Only one study by Othman et al.
[317] focused on the treatment of acute AF. The authors
compared the bilateral (group 1) or posterior (group 2)
use of Botulinum toxin in patients with AF. In both
groups healing of the AF has been reached in 5.20 and
5.40 weeks, respectively, whereas pain relief occurred earl-
ier in group 2 (8.45 vs 7.2 days). The authors concluded
that the use of a single posterior injection is more toler-
able and less painful than bilateral injection [317]. Few
other studies analyzed the role of Botulinum toxin for the
treatment of chronic AF [318, 319]. The results of these
studies regarding the dose, preparation, and the site of in-
jection are interesting but cannot be extended to the treat-
ment of acute anal fissures.
7.E - in patients with an acute anal fissure, is there
a role for antibiotic therapy?
In patients with acute anal fissure, we suggest the
use of topical antibiotics in case of potential reduced
therapeutic compliance or poor genital hygiene
(weak recommendation based on very low-quality
evidences, 2D).
According to Garg, the use of antibiotics should be re-
served for chronic or acute-on-chronic AF in which
there can be a low-grade infection [320]. In a recent pro-
spective controlled randomized study [321], 100 patients
with acute AF were randomly divided into two groups
(group 1: 5% lidocaine; group 2: 5% lidocaine plus
metronidazole cream). All patients applied the therapy 3
times per day for 4 weeks. Pain was assessed using a vis-
ual analog scale. At the end of 2nd and 4th week, there
was a statistically significant difference between the two
groups and in both cases in favor of group 2 (2 weeks
3.3 vs 2.6, p = 0.004;4 weeks 2.47 vs 1.36, p < 0.001).
The final healing rate was 56% in group 1 and 86% in
group 2. The authors suggested the use of metrodinazole
in addition to the traditional therapies.
However, considering the methodological limitations
of the study and the absence of additional evidence, the
recommendations on the use of antibiotics in the treat-
ment of acute AF is weak.
7.F - in patients with an acute anal fissure, what
are the indications for surgical treatment and what
is the appropriate timing for surgery? If indicated,
what is the most appropriate surgical approach?
In patients with acute anal fissure, we suggest
against surgical treatment (weak recommendation
based on moderate quality evidences, 2B).
In patients with anal fissure, we suggest surgical
treatment in the chronic phase, if non-responsive
after 8 weeks non-operative management (strong rec-
ommendation based on moderate quality evidences,
1B).
Patients with an acute AF should be managed with a
combination of dietary and lifestyle modification and
medical therapy. A surgical approach is suggested only
in the chronic phase, after the failure of 6–8 weeks of
NOM. In this context, lateral internal sphincterotomy is
the preferred technique with a lower recurrence rate, a
higher patient satisfaction [295, 305], and a healing rate
of over 90% [322]. Open and closed lateral internal
sphincterotomy have similar results although in a pro-
spective randomized study, open lateral internal sphinc-
terotomy was associated with higher post-operative pain
and a delayed wound healing at 1 year [323]. Both tech-
niques are superior with respect to fissurectomy and
posterior sphincterotomy in terms of healing rate, post-
operative pain, and fecal incontinence.
Conclusions
Anorectal emergencies are common causes of ED refer-
ral and comprise a great variety of diseases, ranging from
benign to life-threatening. Currently, there are no guide-
lines available in the literature addressing the specific
setting of acute care surgery for anorectal disease. For
these reasons, these guidelines present evidence-based
international consensus statements on the management
of anorectal emergencies from collaboration of a panel
of experts and are intended to improve the knowledge
and the awareness of physicians around the world on
this specific topic. The structure of the guidelines, di-
vided into seven main topics that cover the entire man-
agement process of patients with anorectal emergencies,
provides an up-to-date, easy-to-use tool that can help
physicians and surgeons during the decision-making
process.
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